Etoposide
Information
- Drug Name
- Etoposide
- Description
- Entry(CIViC)
- 4
CIViC
Annotation
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03458260 | Active, not recruiting | Phase 2 | Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma | March 26, 2018 | March 2025 |
| NCT03017326 | Active, not recruiting | Phase 3 | Paediatric Hepatic International Tumour Trial | August 24, 2017 | August 1, 2027 |
| NCT02262325 | Active, not recruiting | Phase 2 | Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery | June 8, 2015 | December 31, 2024 |
| NCT03016871 | Active, not recruiting | Phase 2 | Nivolumab, Ifosfamide, Carboplatin, and Etoposide as Second-Line Therapy in Treating Patients With Refractory or Relapsed HL | April 24, 2017 | January 30, 2026 |
| NCT00077285 | Active, not recruiting | Phase 2 | Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma | October 2003 | October 2024 |
| NCT02794571 | Active, not recruiting | Phase 1 | Safety and Pharmacokinetics (PK) of Escalating Doses of Tiragolumab as a Single Agent and in Combination With Atezolizumab and/or Other Anti-Cancer Therapies in Locally Advanced or Metastatic Tumors | May 23, 2016 | October 5, 2024 |
| NCT00792948 | Active, not recruiting | Phase 2 | Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia | September 1, 2009 | January 6, 2025 |
| NCT00470223 | Active, not recruiting | Phase 3 | Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma | March 2007 | December 2026 |
| NCT04256421 | Active, not recruiting | Phase 3 | A Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer | February 4, 2020 | April 15, 2026 |
| NCT02227199 | Active, not recruiting | Phase 1/Phase 2 | Brentuximab Vedotin, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma | October 10, 2014 | September 30, 2025 |
| NCT00476190 | Active, not recruiting | Phase 2 | ALL Adult Consortium Trial: Adult ALL Trial | April 2007 | December 2024 |
| NCT02213913 | Active, not recruiting | Phase 1/Phase 2 | Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas | July 29, 2014 | July 29, 2023 |
| NCT03984448 | Active, not recruiting | Phase 2/Phase 3 | Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas | October 22, 2019 | April 1, 2028 |
| NCT03407144 | Active, not recruiting | Phase 2 | Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667) | April 9, 2018 | February 13, 2027 |
| NCT02481310 | Active, not recruiting | Phase 1/Phase 2 | Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma | October 28, 2015 | July 2024 |
| NCT03382561 | Active, not recruiting | Phase 2 | Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer | May 2, 2018 | December 31, 2024 |
| NCT03064867 | Active, not recruiting | Phase 1/Phase 2 | Venetoclax Plus R-ICE Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma | June 26, 2017 | August 12, 2023 |
| NCT00869232 | Active, not recruiting | Phase 2 | UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete Remission | October 2008 | October 2024 |
| NCT03004287 | Active, not recruiting | Phase 2 | 2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance Therapy | July 1, 2017 | October 2025 |
| NCT00871013 | Active, not recruiting | Phase 2 | Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy | March 2009 | December 2024 |
| NCT00878254 | Active, not recruiting | Phase 2 | Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell Lymphoma | March 25, 2009 | September 2027 |
| NCT02176967 | Active, not recruiting | Phase 3 | Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma | August 8, 2014 | September 30, 2026 |
| NCT05224141 | Active, not recruiting | Phase 3 | Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008, KEYVIBE-008) | March 24, 2022 | June 7, 2027 |
| NCT02443077 | Active, not recruiting | Phase 3 | Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma | October 12, 2016 | May 10, 2025 |
| NCT02166463 | Active, not recruiting | Phase 3 | Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma | March 19, 2015 | September 22, 2024 |
| NCT05192889 | Active, not recruiting | Phase 1/Phase 2 | Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax | August 25, 2022 | July 2029 |
| NCT04101357 | Active, not recruiting | Phase 1/Phase 2 | Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411 | June 19, 2020 | July 2024 |
| NCT02153580 | Active, not recruiting | Phase 1 | Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia | September 24, 2014 | December 31, 2024 |
| NCT04774380 | Active, not recruiting | Phase 3 | Study of Durvalumab in Combination With Platinum and Etoposide for the First Line Treatment of Patients With Extensive-stage Small Cell Lung Cancer | November 11, 2021 | December 31, 2024 |
| NCT03937843 | Active, not recruiting | Phase 2 | Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma | July 29, 2019 | December 31, 2046 |
| NCT02661503 | Active, not recruiting | Phase 3 | HD21 for Advanced Stages | July 2016 | September 2025 |
| NCT00526396 | Active, not recruiting | Phase 3 | STAD-1 Small Cell Lung Cancer Toxicity Adjusted Dosing Study | September 2007 | December 2023 |
| NCT02114229 | Active, not recruiting | Phase 2 | Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors | May 14, 2014 | September 2027 |
| NCT03043872 | Active, not recruiting | Phase 3 | Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN) | March 27, 2017 | December 31, 2024 |
| NCT00534430 | Active, not recruiting | Phase 2 | Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic Cancer | February 29, 2000 | December 30, 2024 |
| NCT02112916 | Active, not recruiting | Phase 3 | Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma | October 4, 2014 | September 22, 2024 |
| NCT00534469 | Active, not recruiting | Phase 2 | Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R | February 8, 2000 | December 30, 2024 |
| NCT02101853 | Active, not recruiting | Phase 3 | Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia | December 17, 2014 | September 22, 2024 |
| NCT02632708 | Active, not recruiting | Phase 1 | Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 Mutation | December 31, 2015 | July 2024 |
| NCT02628405 | Active, not recruiting | Phase 1/Phase 2 | R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma | May 20, 2016 | December 20, 2025 |
| NCT02402920 | Active, not recruiting | Phase 1 | Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer | July 22, 2015 | July 31, 2025 |
| NCT03786783 | Active, not recruiting | Phase 2 | Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma | March 4, 2019 | September 22, 2024 |
| NCT04472949 | Active, not recruiting | Phase 2 | Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab in Extensive-stage Disease Small Cell Lung Cancer (ED-SCLC). | June 25, 2021 | December 2027 |
| NCT00544115 | Active, not recruiting | Phase 2 | Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders | October 16, 2001 | December 30, 2024 |
| NCT00092222 | Active, not recruiting | Phase 2 | Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity | October 28, 2004 | October 1, 2025 |
| NCT03164057 | Active, not recruiting | Phase 2 | A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia | June 15, 2017 | June 2027 |
| NCT03749018 | Active, not recruiting | Phase 2 | Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma | January 2, 2019 | July 31, 2024 |
| NCT03586999 | Active, not recruiting | Phase 1/Phase 2 | Nivolumab With Standard of Care Chemotherapy for Peripheral T Cell Lymphomas | November 7, 2018 | December 2024 |
| NCT04951115 | Active, not recruiting | Phase 2 | A Trial With Chemotherapy, Immunotherapy, and Radiotherapy for Patients With Newly Diagnosed Stage IV Small Cell Lung Cancer | July 12, 2021 | July 1, 2025 |
| NCT02003222 | Active, not recruiting | Phase 3 | Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia | May 19, 2014 | December 4, 2024 |
| NCT00554788 | Active, not recruiting | Phase 3 | Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma | February 4, 2008 | December 31, 2024 |
| NCT02595424 | Active, not recruiting | Phase 2 | Cisplatin, Carboplatin and Etoposide or Temozolomide and Capecitabine in Treating Patients With Neuroendocrine Carcinoma of the Gastrointestinal Tract or Pancreas That Is Metastatic or Cannot Be Removed by Surgery | April 6, 2016 | January 1, 2029 |
| NCT00557193 | Active, not recruiting | Phase 3 | Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | January 15, 2008 | June 28, 2024 |
| NCT03141359 | Active, not recruiting | Phase 2 | Use of High Dose Radiation Followed by Chemotherapy and Radiation to Treat Locally Advanced NSCLC | May 12, 2017 | July 2027 |
| NCT01085617 | Active, not recruiting | Phase 3 | Standard Chemotherapy With or Without Nelarabine or Rituximab in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | December 2010 | December 2025 |
| NCT01096368 | Active, not recruiting | Phase 3 | Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma | May 7, 2010 | September 22, 2024 |
| NCT00334815 | Active, not recruiting | Phase 2 | Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery | June 15, 2006 | February 22, 2025 |
| NCT02964013 | Active, not recruiting | Phase 1 | Study of Vibostolimab Alone and in Combination With Pembrolizumab in Advanced Solid Tumors (MK-7684-001) ( KEYVIBE-001) | December 13, 2016 | August 1, 2024 |
| NCT00104676 | Active, not recruiting | Phase 3 | Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors | November 26, 2003 | December 2024 |
| NCT00572169 | Active, not recruiting | Phase 3 | UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total Therapy | November 2006 | August 2025 |
| NCT05091567 | Active, not recruiting | Phase 3 | A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer | November 18, 2021 | March 6, 2026 |
| NCT00576979 | Active, not recruiting | Phase 1/Phase 2 | Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia | March 4, 2008 | December 30, 2024 |
| NCT00336024 | Active, not recruiting | Phase 3 | Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma | August 6, 2007 | December 31, 2028 |
| NCT03568994 | Active, not recruiting | Early Phase 1 | Atovaquone (Mepron®) Combined With Conventional Chemotherapy for de Novo Acute Myeloid Leukemia (AML) | July 10, 2018 | October 31, 2025 |
| NCT04745689 | Active, not recruiting | Phase 2 | Study of AZD2811 + Durvalumab in ES-SCLC | February 23, 2021 | March 31, 2023 |
| NCT02553460 | Active, not recruiting | Phase 1/Phase 2 | Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I | January 29, 2016 | October 2031 |
| NCT01993810 | Active, not recruiting | Phase 3 | Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer | February 3, 2014 | October 2025 |
| NCT00110110 | Active, not recruiting | Phase 2 | Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma | June 2004 | December 31, 2024 |
| NCT04665856 | Active, not recruiting | Phase 3 | Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer | December 22, 2020 | April 15, 2025 |
| NCT04092283 | Active, not recruiting | Phase 3 | Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer | April 29, 2020 | December 31, 2028 |
| NCT03117751 | Active, not recruiting | Phase 2/Phase 3 | Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma | March 29, 2017 | March 31, 2028 |
| NCT02896582 | Active, not recruiting | Phase 2 | Efficacy of Upfront and Maintenance Obinutuzumab in Mantle Cell Lymphoma Treated by DHAP and MRD Driven Maintenance | October 2016 | March 2025 |
| NCT02521493 | Active, not recruiting | Phase 3 | Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome | December 23, 2015 | June 30, 2024 |
| NCT02342782 | Active, not recruiting | Phase 1 | Yttrium Y 90 Basiliximab and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Mature T-cell Non-Hodgkin Lymphoma | June 8, 2020 | December 31, 2024 |
| NCT01231906 | Active, not recruiting | Phase 3 | Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma | November 22, 2010 | |
| NCT02883049 | Active, not recruiting | Phase 3 | Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations | February 29, 2012 | September 22, 2024 |
| NCT05309629 | Active, not recruiting | Phase 2 | Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy in Extensive-Stage Small Cell Lung Cancer | April 18, 2022 | November 1, 2024 |
| NCT01959698 | Active, not recruiting | Phase 1 | Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma | April 17, 2014 | June 1, 2025 |
| NCT04730999 | Active, not recruiting | Phase 2 | Efficacy and Safety Study of a New Therapeutic Strategy in the Treatment of Extended-Disease Small-Cell Lung Cancer | July 1, 2020 | October 17, 2024 |
| NCT02338518 | Active, not recruiting | Phase 3 | Comparison of SEEOX and SOX Regimens in Stage ⅢB/ⅢC Gastric Cancer Patients | January 4, 2015 | October 2023 |
| NCT03567642 | Active, not recruiting | Phase 1 | A Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung Cancers | June 12, 2018 | June 2024 |
| NCT02337985 | Active, not recruiting | Phase 1 | Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma | November 20, 2015 | December 31, 2024 |
| NCT02329080 | Active, not recruiting | Phase 2 | New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement | December 2014 | December 2023 |
| NCT00632853 | Active, not recruiting | Phase 3 | Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide | March 2008 | |
| NCT01946529 | Active, not recruiting | Phase 2 | Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors | December 27, 2013 | July 2026 |
| NCT01371981 | Active, not recruiting | Phase 3 | Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia | June 20, 2011 | September 30, 2027 |
| NCT00379340 | Active, not recruiting | Phase 3 | Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor | February 26, 2007 | |
| NCT01920932 | Active, not recruiting | Phase 2 | Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma | August 12, 2013 | May 2028 |
| NCT00641381 | Active, not recruiting | Phase 1 | Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma | May 10, 2000 | December 30, 2024 |
| NCT03850067 | Active, not recruiting | Phase 1 | A Safety, Tolerability and Preliminary Efficacy Evaluation of CC-90011 Given in Combination With Cisplatin and Etoposide in Subjects With First Line, Extensive Stage Small Cell Lung Cancer | March 12, 2019 | June 26, 2024 |
| NCT01873326 | Active, not recruiting | Phase 2 | Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors | June 2013 | June 2024 |
| NCT04047862 | Active, not recruiting | Phase 1 | Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors | August 26, 2019 | August 2024 |
| NCT03113500 | Active, not recruiting | Phase 2 | Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma | May 25, 2017 | December 21, 2024 |
| NCT04380636 | Active, not recruiting | Phase 3 | Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012) | July 6, 2020 | February 15, 2027 |
| NCT03533582 | Active, not recruiting | Phase 2/Phase 3 | Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery | May 24, 2018 | June 30, 2026 |
| NCT03020030 | Active, not recruiting | Phase 3 | Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents | March 3, 2017 | November 2034 |
| NCT01871766 | Active, not recruiting | Phase 2 | Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy | December 4, 2013 | June 2030 |
| NCT01476839 | Active, not recruiting | Phase 1 | Radiolabeled Monoclonal Antibody Therapy and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Primary Refractory or Relapsed Hodgkin Lymphoma | November 9, 2012 | December 31, 2024 |
| NCT02306161 | Active, not recruiting | Phase 3 | Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma | December 12, 2014 | September 22, 2024 |
| NCT01864109 | Active, not recruiting | Phase 2 | Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma | May 2013 | May 2027 |
| NCT01857934 | Active, not recruiting | Phase 2 | Therapy for Children With Advanced Stage Neuroblastoma | July 5, 2013 | December 2024 |
| NCT03980925 | Active, not recruiting | Phase 2 | Platinum-doublet Chemotherapy and Nivolumab for the Treatment of Subjects With Neuroendocrine Neoplasms (NENs) of the Gastroenteropancreatic (GEP) Tract or of Unknown (UK) Origin. | October 11, 2019 | December 2023 |
| NCT01511562 | Active, not recruiting | Phase 2 | Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma | September 2012 | |
| NCT03517137 | Active, not recruiting | Phase 2 | Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study | August 1, 2019 | November 16, 2026 |
| NCT04665765 | Active, not recruiting | Phase 2 | Polatuzumab Vedotin, Rituximab, Ifosfamide, Carboplatin, and Etoposide (PolaR-ICE) as Initial Salvage Therapy for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma | January 18, 2021 | March 31, 2024 |
| NCT03944772 | Active, not recruiting | Phase 2 | Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD) | June 25, 2019 | May 6, 2025 |
| NCT01840566 | Active, not recruiting | Phase 1 | High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma | April 2013 | April 2025 |
| NCT03077828 | Active, not recruiting | Phase 2 | Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma | April 21, 2017 | December 2024 |
| NCT04924101 | Active, not recruiting | Phase 2 | Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99) | July 15, 2021 | July 14, 2026 |
| NCT01798004 | Active, not recruiting | Phase 1 | Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma | April 8, 2013 | |
| NCT03811002 | Active, not recruiting | Phase 3 | Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC) | July 26, 2019 | December 28, 2026 |
| NCT02815592 | Active, not recruiting | Phase 1 | Trial of BMS-986012 in Combination With Platinum and Etoposide | November 28, 2016 | June 3, 2024 |
| NCT01602666 | Active, not recruiting | Phase 2 | Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors | June 27, 2012 | June 30, 2024 |
| NCT00716066 | Active, not recruiting | Phase 2 | Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases | June 2008 | January 31, 2030 |
| NCT04293562 | Active, not recruiting | Phase 3 | A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations | July 21, 2020 | September 30, 2027 |
| NCT01783535 | Active, not recruiting | Phase 2 | Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma | June 19, 2013 | January 2028 |
| NCT05008224 | Active, not recruiting | Phase 2 | Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11) | October 7, 2021 | May 22, 2024 |
| NCT02797470 | Active, not recruiting | Phase 1/Phase 2 | Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant | June 23, 2016 | June 30, 2025 |
| NCT04622228 | Active, not recruiting | Phase 2 | Study of Low-Dose Radiotherapy (LDRT) Concurrent Cisplatin/Carboplatin Plus Etoposide With Atezolizumab for Patients With Extensive-Stage Small Cell Lung Cancer | December 16, 2020 | June 30, 2024 |
| NCT03467256 | Active, not recruiting | Phase 1/Phase 2 | CD19 T-CAR for Treatment of Children and Young Adults With r/r B-ALL | May 14, 2018 | October 15, 2025 |
| NCT00003727 | Completed | Phase 2 | Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia | March 1999 | February 2008 |
| NCT04028050 | Completed | Phase 3 | A Study of Atezolizumab in Combination With Carboplatin Plus Etoposide to Investigate Safety and Efficacy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer | August 12, 2019 | July 13, 2023 |
| NCT00003783 | Completed | Phase 2 | Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia | March 1999 | March 2007 |
| NCT00003811 | Completed | Phase 2 | Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors | April 2000 | September 2007 |
| NCT00003812 | Completed | Phase 2 | Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | March 1999 | March 2006 |
| NCT03991884 | Completed | Phase 1 | Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia | September 24, 2019 | June 28, 2023 |
| NCT00003816 | Completed | Phase 2/Phase 3 | Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer | October 19, 1998 | July 12, 2019 |
| NCT00003859 | Completed | Phase 3 | Surgery Plus Radiation Therapy With or Without Chemotherapy in Treating Children With Primitive Neuroectodermal Tumors of the CNS | April 1992 | April 2003 |
| NCT00003860 | Completed | Phase 2 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Small Cell Lung Cancer | September 1998 | September 2005 |
| NCT00003875 | Completed | Phase 2 | Busulfan and Etoposide Followed by Peripheral Blood Stem Cell Transplant and Low-Dose Aldesleukin in Treating Patients With Acute Myeloid Leukemia | October 13, 1998 | June 11, 2015 |
| NCT00003935 | Completed | Phase 1 | Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma | September 1999 | March 2007 |
| NCT00003937 | Completed | Phase 3 | Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma | September 1999 | June 2008 |
| NCT00003941 | Completed | Phase 3 | Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer | April 1999 | |
| NCT00003957 | Completed | Phase 2 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma | December 1998 | August 2001 |
| NCT00003967 | Completed | Phase 1 | Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer | September 1999 | |
| NCT00003996 | Completed | Phase 2 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | May 1999 | May 2008 |
| NCT00004006 | Completed | Phase 2 | Combination Chemotherapy, Radiation Therapy, and Bone Marrow Transplantation in Treating Patients With Retinoblastoma | November 1997 | September 2005 |
| NCT00004010 | Completed | Phase 2 | Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease | October 1999 | June 2008 |
| NCT00004031 | Completed | Phase 3 | SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma | July 1997 | October 31, 2013 |
| NCT00004054 | Completed | Phase 3 | Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer | January 2000 | November 2013 |
| NCT00004061 | Completed | Phase 2 | Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer | May 1999 | December 2009 |
| NCT00004110 | Completed | Phase 2 | Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma | August 1999 | |
| NCT00004132 | Completed | Phase 2 | Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer | January 2000 | May 2004 |
| NCT00004169 | Completed | Phase 2 | Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hodgkin's Disease | November 1993 | January 2007 |
| NCT00004176 | Completed | Phase 2 | Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | October 1998 | February 2001 |
| NCT00004186 | Completed | Phase 1/Phase 2 | Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer | December 1996 | December 2004 |
| NCT00004188 | Completed | Phase 3 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma | February 2001 | |
| NCT00004192 | Completed | Phase 2 | Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma | May 1, 2000 | March 16, 2001 |
| NCT00004224 | Completed | Phase 2 | Combination Chemotherapy Followed by Radiation Therapy in Treating Children With Localized Ependymoma | January 1999 | March 2008 |
| NCT00004898 | Completed | Phase 1/Phase 2 | Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic Leukemia | October 1999 | July 2003 |
| NCT00004899 | Completed | Phase 2 | Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome | October 1999 | August 2004 |
| NCT00004900 | Completed | Phase 2 | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer | October 1999 | August 2004 |
| NCT00004904 | Completed | Phase 1 | Stem Cell Transplantation in Treating Patients With Hematologic Cancer | October 1999 | July 2000 |
| NCT00004905 | Completed | Phase 2 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia | October 1999 | September 2004 |
| NCT00004906 | Completed | Phase 2 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer | October 1999 | June 2001 |
| NCT00004907 | Completed | Phase 1/Phase 2 | Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's Lymphoma | October 1999 | August 2004 |
| NCT00005022 | Completed | Phase 1 | Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer | February 1998 | June 2010 |
| NCT03901118 | Completed | Phase 2 | Chiauranib in Combination With Chemotherapy in Patients With Ovarian Cancer | July 1, 2019 | December 18, 2020 |
| NCT00005578 | Completed | Phase 3 | Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease | March 1997 | June 2008 |
| NCT00005589 | Completed | Phase 3 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma | October 1999 | April 2013 |
| NCT00005613 | Completed | Phase 2 | Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease | March 1996 | June 2010 |
| NCT00005631 | Completed | Phase 2 | Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Large Cell Lymphoma | November 1999 | November 2002 |
| NCT00005793 | Completed | Phase 1/Phase 2 | A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide | July 1999 | November 2006 |
| NCT00005802 | Completed | Phase 1/Phase 2 | Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia | June 1999 | March 2005 |
| NCT00005803 | Completed | Phase 1/Phase 2 | Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma | September 1999 | October 2018 |
| NCT00005823 | Completed | Phase 3 | Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome | December 1998 | December 2007 |
| NCT00005863 | Completed | Phase 3 | Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia | August 1998 | December 2004 |
| NCT00005867 | Completed | Phase 3 | Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma | January 1998 | August 2007 |
| NCT00005946 | Completed | Phase 1 | Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation | October 2000 | June 2002 |
| NCT00005964 | Completed | Phase 2 | Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Previously Untreated Aggressive Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma | May 2000 | March 2006 |
| NCT00005977 | Completed | Phase 3 | Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia | September 2000 | September 2006 |
| NCT00005978 | Completed | Phase 1 | N99-01: Combination Chemotherapy, Radiation Therapy, and Stem Cell Transplantation in Treating Patients With Neuroblastoma | May 2000 | |
| NCT00005985 | Completed | Phase 2 | Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma | August 2000 | February 2007 |
| NCT03794167 | Completed | Phase 2 | BuCE Versus BuME as Conditioning Therapy in Non-Hodgkin's Lymphoma | June 1, 2012 | November 30, 2018 |
| NCT03792815 | Completed | Phase 2 | Busulfan, Melphalan and Etoposide as Conditioning for Autologous Transplantation for Non-Hodgkin's Lymphoma (NHL) | October 2009 | September 2013 |
| NCT00006012 | Completed | Phase 1/Phase 2 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | February 2001 | May 2006 |
| NCT00006040 | Completed | Phase 1 | Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory Leukemia | April 2000 | November 2003 |
| NCT03582475 | Completed | Phase 1 | Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate | December 20, 2018 | May 16, 2022 |
| NCT00006122 | Completed | Phase 2 | Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia | June 2000 | |
| NCT00006184 | Completed | Phase 2 | Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma | February 8, 2001 | January 12, 2008 |
| NCT00006258 | Completed | Phase 2 | Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma | November 1997 | January 2005 |
| NCT00006260 | Completed | Phase 2 | Combination Chemotherapy in Treating Patients With Metastatic Breast Cancer | May 1997 | |
| NCT00006363 | Completed | Phase 3 | Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia | November 2000 | |
| NCT00006373 | Completed | Phase 2 | Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma | February 2000 | December 2011 |
| NCT00006455 | Completed | Phase 3 | Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma (ALCL 99) | November 26, 1999 | September 3, 2020 |
| NCT00006461 | Completed | Phase 3 | Combination Chemotherapy Followed by Second-Look Surgery and Radiation Therapy in Treating Children With Nonmetastatic Medulloblastoma or Primitive Neuroectodermal Tumor | October 2000 | |
| NCT00006487 | Completed | Phase 1 | S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung Cancer | October 2000 | July 2004 |
| NCT00006695 | Completed | Phase 2 | Monoclonal Antibody Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplant in Non-Hodgkin's Lymphoma | April 1, 2000 | December 16, 2014 |
| NCT00006734 | Completed | Phase 3 | Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor | May 2001 | June 30, 2023 |
| NCT00006747 | Completed | Phase 2 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma | November 2000 | February 2003 |
| NCT00007813 | Completed | Phase 1 | Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors | May 31, 1997 | February 1, 2005 |
| NCT00007852 | Completed | Phase 2 | Rituximab & Combination Chemotherapy Followed by Transplantation in Relapsed or Refractory Non-Hodgkin's Lymphoma | September 1, 2000 | January 1, 2011 |
| NCT00007865 | Completed | Phase 2 | Combination Chemotherapy Plus Rituximab in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma | September 1, 2000 | April 22, 2008 |
| NCT00007982 | Completed | Phase 2 | Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer | April 1999 | May 2008 |
| NCT00008190 | Completed | Phase 2 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute Leukemia | March 1999 | May 2008 |
| NCT00012051 | Completed | Phase 3 | Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma | September 2000 | October 2007 |
| NCT03432598 | Completed | Phase 2 | Anti-PD-1 in Combination With Chemotherapy as First-Line Treatment to Lung Cancer | August 24, 2017 | December 21, 2020 |
| NCT00017225 | Completed | Phase 2 | Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma | May 1997 | February 2002 |
| NCT00017251 | Completed | Phase 1 | Combination Chemotherapy Plus Oblimersen in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer | April 2001 | |
| NCT00017368 | Completed | Phase 2 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma | April 2001 | January 2012 |
| NCT00018954 | Completed | Phase 2 | Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma | October 1992 | October 2002 |
| NCT03328104 | Completed | Phase 1 | Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma | July 24, 2018 | June 29, 2023 |
| NCT00020709 | Completed | Phase 3 | Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | June 2001 | |
| NCT00020943 | Completed | Phase 2 | Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma | June 2001 | September 2009 |
| NCT00022737 | Completed | Phase 3 | Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia | October 2002 | |
| NCT00023998 | Completed | Phase 2 | Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma | July 2001 | May 2007 |
| NCT03161054 | Completed | Phase 2 | Metronomic Chemotherapy in Elderly Non-fit Patients With Aggressive B-Cell Lymphomas | September 12, 2017 | June 21, 2021 |
| NCT03132532 | Completed | Phase 2 | Platinum Doublet Chemotherapy and Proton Beam Radiation Therapy in Treating Patients With Stage II-III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery | July 31, 2017 | December 31, 2023 |
| NCT00025259 | Completed | Phase 3 | Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease | September 2002 | |
| NCT00025272 | Completed | Phase 2 | Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer | November 1, 2001 | January 18, 2005 |
| NCT03118466 | Completed | Phase 2 | Mitoxantrone, Etoposide, and Cytarabine (MEC) Plus Lenalidomide for Relapsed or Refractory Acute Myeloid Leukemia | September 25, 2017 | August 18, 2021 |
| NCT00025363 | Completed | Phase 2 | Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma | November 2001 | |
| NCT00025428 | Completed | Phase 3 | Combination Chemotherapy Before Surgery in Treating Children With Localized Neuroblastoma | December 2000 | November 2013 |
| NCT00025441 | Completed | Phase 2 | Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors | November 1998 | March 2010 |
| NCT00025597 | Completed | Phase 2 | Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma. | July 1999 | February 2011 |
| NCT00025610 | Completed | Phase 2 | Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma | July 1999 | March 2009 |
| NCT00025623 | Completed | Phase 2 | Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma | July 1999 | March 2009 |
| NCT00025649 | Completed | Phase 2 | Combination Chemotherapy Followed by Surgery and Peripheral Stem Cell or Bone Marrow Transplantation in Treating Infants With Newly Diagnosed Neuroblastoma | July 1999 | March 2009 |
| NCT00026208 | Completed | Phase 2 | Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma | June 2001 | February 13, 2017 |
| NCT00027846 | Completed | Phase 2 | Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma | August 2003 | March 31, 2016 |
| NCT00027898 | Completed | Phase 1 | Bortezomib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | January 2002 | |
| NCT00028665 | Completed | Phase 2 | Cyclophosphamide W/or W/Out Rituximab and Peripheral Stem Cell Transplantation in Patients With Recurrent Non-Hodgkin's Lymphoma | June 2000 | |
| NCT00028769 | Completed | Phase 2 | S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer | December 2001 | July 2011 |
| NCT03072771 | Completed | Phase 1 | Blinatumomab Consolidation Post Autologous Stem Cell Transplantation in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) | August 1, 2017 | October 30, 2023 |
| NCT00032019 | Completed | Phase 2 | Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma | February 2002 | April 2009 |
| NCT03066778 | Completed | Phase 3 | A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604) | May 2, 2017 | September 21, 2021 |
| NCT00033696 | Completed | Phase 2 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | September 2001 | April 2009 |
| NCT00039130 | Completed | Phase 2 | Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia | May 2002 | October 2014 |
| NCT00039195 | Completed | Phase 2 | Chemotherapy and Rituximab With or Without Total-Body Irradiation and Peripheral Stem Cell Transplant in Treating Patients With Lymphoma | November 2006 | January 2010 |
| NCT00039377 | Completed | Phase 2 | Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | April 2002 | February 2014 |
| NCT00040690 | Completed | Phase 2 | Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia | November 2008 | December 2008 |
| NCT00040872 | Completed | Phase 2 | Multiple Therapies in Treating Patients With Advanced Neuroblastoma | June 2000 | January 2007 |
| NCT00041015 | Completed | Phase 3 | Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer | September 2001 | November 2002 |
| NCT00041054 | Completed | Phase 2 | Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer | June 2002 | February 2008 |
| NCT00041327 | Completed | Phase 2 | Combination Chemotherapy Followed By Antiviral Therapy and Interferon Alfa in Treating Patients With HTLV-1-Related Adult T-Cell Leukemia/Lymphoma | October 2002 | December 2006 |
| NCT03059667 | Completed | Phase 2 | Immunotherapy as Second-line in Patient With Small Cell Lung Cancer | March 13, 2017 | December 1, 2020 |
| NCT00042978 | Completed | Phase 2 | Carboplatin and Etoposide With or Without Oblimersen Sodium in Treating Patients With Extensive Stage Small Cell Lung Cancer | April 2003 | |
| NCT00043979 | Completed | Phase 2 | Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas | September 19, 2002 | December 14, 2011 |
| NCT00045162 | Completed | Phase 3 | S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer | November 2002 | December 2009 |
| NCT03036904 | Completed | Phase 1 | Study of Venetoclax Plus DA-EPOCH-R for the Treatment of Aggressive B-Cell Lymphomas | February 6, 2017 | November 11, 2021 |
| NCT00047281 | Completed | Phase 2 | Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma | March 2004 | February 2006 |
| NCT00047320 | Completed | Phase 2 | Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors | January 2004 | February 2009 |
| NCT00049036 | Completed | Phase 2 | Combination Chemotherapy and Rituximab in Treating Patients With HIV-Associated Stage I, Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma | March 2003 | May 2009 |
| NCT00049218 | Completed | Phase 1/Phase 2 | Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer | April 2003 | May 2014 |
| NCT00049439 | Completed | Phase 2 | Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma | March 1998 | February 2008 |
| NCT00049569 | Completed | N/A | Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia | January 2003 | |
| NCT00049595 | Completed | Phase 3 | Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma | August 2002 | |
| NCT00051311 | Completed | Phase 2 | Modified Stem Cell Transplant Procedure to Treat Patients With Blood and Immune System Cancers | January 3, 2003 | September 25, 2014 |
| NCT00052299 | Completed | Phase 3 | Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia | September 2002 | February 2012 |
| NCT00052923 | Completed | Phase 3 | Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma | March 2003 | |
| NCT00053118 | Completed | Phase 1 | Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer | March 2002 | July 2004 |
| NCT00053352 | Completed | Phase 3 | Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors | November 3, 2003 | June 30, 2021 |
| NCT00053768 | Completed | Phase 3 | Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma | April 2002 | December 5, 2006 |
| NCT00054327 | Completed | Phase 2 | Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer | November 2000 | September 2011 |
| NCT00054665 | Completed | Phase 2 | PS-341 Alone and PS-341 Plus EPOCH Chemotherapy to Treat Non-Hodgkin's Lymphoma | February 2003 | July 2009 |
| NCT00057811 | Completed | Phase 2 | Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma | June 2004 | July 2014 |
| NCT00057837 | Completed | Phase 2 | Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer | July 14, 2004 | August 2012 |
| NCT00058292 | Completed | Phase 1 | Radiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | April 2000 | March 2009 |
| NCT03023046 | Completed | Phase 2 | Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma | February 23, 2017 | May 1, 2022 |
| NCT00060255 | Completed | Phase 2 | High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors | December 1991 | February 2013 |
| NCT00061893 | Completed | Phase 2 | Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors | April 2004 | December 2013 |
| NCT00062439 | Completed | Phase 2 | S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors | July 2003 | December 2010 |
| NCT00066222 | Completed | Phase 2 | Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | June 2003 | November 2013 |
| NCT00066482 | Completed | N/A | Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors | July 2004 | |
| NCT00066742 | Completed | Phase 2 | Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer | September 2003 | August 2009 |
| NCT00070174 | Completed | Phase 2 | Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy | December 2003 | December 2013 |
| NCT00070187 | Completed | Phase 2/Phase 3 | Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma | November 2003 | |
| NCT00070200 | Completed | Phase 1 | Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma | March 2004 | December 2013 |
| NCT03019640 | Completed | Phase 2 | Umbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma | October 10, 2017 | August 16, 2021 |
| NCT00072384 | Completed | Phase 3 | Systemic Chemotherapy and Subtenon Carboplatin, and Local Ophthalmic Therapy in Children With Intraocular Retinoblastoma | April 16, 2007 | June 30, 2021 |
| NCT00072527 | Completed | Phase 2 | Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | November 2003 | January 2013 |
| NCT00073918 | Completed | Phase 2 | Iodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | February 1999 | October 2, 2011 |
| NCT00078988 | Completed | Phase 3 | High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas | October 2004 | September 2006 |
| NCT00079040 | Completed | Phase 2 | Cisplatin, Etoposide, and Bevacizumab in Treating Patients With Previously Untreated Extensive Stage Small Cell Lung Cancer | January 2006 | January 2009 |
| NCT00079105 | Completed | Phase 2 | A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years | January 2004 | December 2010 |
| NCT00080886 | Completed | Phase 2 | Rituximab, Carmustine; Cytarabine, Etoposide, & Melphalan; Stem Cell Transplantation for Non-Hodgkin's Lymphoma | May 8, 2002 | March 12, 2015 |
| NCT00080925 | Completed | Phase 1 | T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies | February 2004 | December 2010 |
| NCT00083161 | Completed | Phase 2 | Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With Extensive-Stage Small Cell Lung Cancer | June 2003 | May 2010 |
| NCT00083538 | Completed | Phase 2 | Study of Tumor Antigen-Pulsed Autologous Dendritic Cell Vaccination Administrated Subcutaneously or Intranodally | February 2001 | December 2007 |
| NCT00083551 | Completed | Phase 3 | UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy | August 1998 | August 2014 |
| NCT00083681 | Completed | Phase 2 | DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse | June 1998 | May 2005 |
| NCT00083915 | Completed | Phase 3 | DTPACE Followed by Tandem Transplant With Melphalan (MEL) 200 Versus MEL/Dexamethasone/Thalidomide (DT) Platinol/Adriamycin/Etoposide (PACE) Hybrid and DTPACE Consolidation | June 2001 | June 2010 |
| NCT00084838 | Completed | Phase 2 | Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT | February 2003 | March 2013 |
| NCT00085098 | Completed | Phase 3 | Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary Central Nervous System (CNS) Germ Cell Tumor | January 2007 | May 2009 |
| NCT00086944 | Completed | Phase 1/Phase 2 | Oblimersen, Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma | May 2004 | |
| NCT00094497 | Completed | Phase 3 | Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT) | June 2004 | December 2010 |
| NCT00096135 | Completed | N/A | Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes | November 2004 | |
| NCT00098774 | Completed | Phase 2 | Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Primary CNS Lymphoma | October 2004 | September 2014 |
| NCT00098839 | Completed | Phase 1/Phase 2 | Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL) | February 2005 | April 2011 |
| NCT00100477 | Completed | Phase 2 | Use of Topotecan in Patients With Refractory Acute Leukemia | August 1998 | June 2001 |
| NCT00107354 | Completed | Phase 1 | Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant | December 1998 | |
| NCT00109031 | Completed | Phase 3 | Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE) | January 2005 | December 2010 |
| NCT00109928 | Completed | Phase 2 | S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma | September 2005 | April 2014 |
| NCT00112853 | Completed | Phase 1 | Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia | March 2005 | |
| NCT00118209 | Completed | Phase 3 | Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma | May 2005 | November 15, 2021 |
| NCT02949895 | Completed | Phase 1 | Study of BMS-986012 in Subjects With Small Cell Lung Caner | November 29, 2016 | August 29, 2017 |
| NCT00134030 | Completed | Phase 3 | Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma | November 14, 2005 | September 30, 2022 |
| NCT00137995 | Completed | Phase 3 | R-ICE Versus R-DHAP in Patients Aged 18-65 With Relapse Diffuse Large B-cell Lymphoma | June 2003 | October 2008 |
| NCT00146120 | Completed | Phase 3 | Risk-Adapted Therapy of Acute Myeloid Leukemia of Adults (18-60 Years) According to the Cytogenetic Result | May 1998 | May 2005 |
| NCT00151060 | Completed | Phase 2 | Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate | December 1998 | June 2006 |
| NCT00151242 | Completed | Phase 2/Phase 3 | Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia | July 2004 | August 2013 |
| NCT00165451 | Completed | Phase 2 | A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer | June 2001 | October 2006 |
| NCT00176605 | Completed | Phase 2 | Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancer | May 2005 | October 2008 |
| NCT00187122 | Completed | N/A | Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma | March 1993 | June 2004 |
| NCT00191139 | Completed | Phase 2 | Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC) | March 2003 | February 2009 |
| NCT00193505 | Completed | Phase 2 | Ifosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in Relapsed/Refractory Intermediate Grade B-Cell Lymphoma | October 2003 | August 2005 |
| NCT00193531 | Completed | Phase 2 | Paclitaxel, Carboplatin, and Oral Etoposide Followed by Weekly Paclitaxel in High Grade Neuroendocrine Carcinoma | December 1998 | January 2007 |
| NCT00193596 | Completed | Phase 3 | Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site | September 2003 | June 2009 |
| NCT00198991 | Completed | Phase 4 | German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003) | April 2003 | June 30, 2013 |
| NCT02867956 | Completed | Phase 2 | Apatinib and Etoposide in Patients With Platinum Resistant or Refractory Ovarian Cancer | August 10, 2016 | September 10, 2019 |
| NCT00204646 | Completed | Phase 2 | Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS) | February 1999 | December 2006 |
| NCT02825147 | Completed | Phase 2 | Pegaspargase and Methotrexate Based Regimens for Newly Diagnosed Extranodal NK/T Cell Lymphoma | September 2013 | July 2017 |
| NCT00216125 | Completed | Phase 3 | Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer | February 2002 | March 2008 |
| NCT00217503 | Completed | Phase 2 | Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion Lymphoma | July 2005 | June 2007 |
| NCT00231582 | Completed | Phase 2 | High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF II | September 2004 | January 2010 |
| NCT00233987 | Completed | Phase 2 | S0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma | October 2005 | December 2017 |
| NCT00238368 | Completed | Phase 2 | Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow Transplant | February 2004 | September 17, 2007 |
| NCT00242996 | Completed | Phase 2 | Rituximab, Cyclophosphamide, and G-CSF Followed By Combination Chemotherapy in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant Followed By Rituximab and GM-CSF for Refractory Diffuse Large B-Cell Lymphoma | March 2004 | April 2007 |
| NCT00244946 | Completed | Phase 1 | Combination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's Lymphoma | March 2004 | March 2013 |
| NCT00253435 | Completed | Phase 2 | N2001-02: I-MIBG With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma | September 2005 | December 2013 |
| NCT00255723 | Completed | Phase 2 | Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed or Refractory Hodgkin's Lymphoma | April 2004 | July 2012 |
| NCT00264953 | Completed | Phase 3 | HD11 for Intermediate Stages | May 1998 | |
| NCT00265031 | Completed | Phase 3 | HD12 for Advanced Stages | January 1999 | |
| NCT00265889 | Completed | Phase 2 | Autologous Stem Cell Transplant in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma | February 2002 | April 2010 |
| NCT00274807 | Completed | Phase 2 | Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia | June 2001 | May 2008 |
| NCT00274924 | Completed | Phase 2 | Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma | September 26, 2006 | March 2019 |
| NCT02786719 | Completed | N/A | High-Risk Neuroblastoma Chemotherapy Without G-CSF | June 2016 | February 5, 2019 |
| NCT00275015 | Completed | Phase 2 | Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia | January 1998 | April 2012 |
| NCT02763579 | Completed | Phase 3 | A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC) | June 7, 2016 | July 7, 2022 |
| NCT02686346 | Completed | Phase 1/Phase 2 | Brentuximab Vedotin in Refractory/Relapsed Hodgkin Lymphoma Treated by ICE | March 2016 | July 12, 2021 |
| NCT00276809 | Completed | Phase 2 | Combination Chemotherapy, Total-Body Irradiation, and Alemtuzumab in Treating Patients Undergoing an Autologous Stem Cell Transplant for Stage I, Stage II, Stage III, or Stage IV Chronic Lymphocytic Leukemia | June 2001 | September 2004 |
| NCT02636322 | Completed | Phase 2 | Smart Start: A Phase II Study of Rituximab, Lenalidomide, and Ibrutinib | March 29, 2016 | October 24, 2022 |
| NCT00303849 | Completed | Phase 1/Phase 2 | Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors | September 15, 2005 | March 12, 2021 |
| NCT00304018 | Completed | Phase 1 | Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer | October 2002 | March 2009 |
| NCT00304070 | Completed | Phase 3 | Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor | May 3, 2007 | June 30, 2023 |
| NCT00304083 | Completed | Phase 2 | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors | December 2005 | June 2014 |
| NCT02626338 | Completed | Phase 1/Phase 2 | Pilot Study of Crenolanib Combined With Standard Salvage Chemotherapy in Subjects With R/R AML | February 2016 | February 2018 |
| NCT00315705 | Completed | Phase 1/Phase 2 | A Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias. | March 2006 | May 2010 |
| NCT00324298 | Completed | Phase 3 | Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles | July 2003 | March 2011 |
| NCT02583893 | Completed | Phase 2 | Biomarkers in Predicting Treatment Response to Sirolimus and Chemotherapy in Patients With High-Risk Acute Myeloid Leukemia | October 7, 2015 | May 17, 2023 |
| NCT02561273 | Completed | Phase 1/Phase 2 | Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma | September 28, 2015 | November 1, 2020 |
| NCT00335556 | Completed | Phase 2 | Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors | June 2006 | |
| NCT00335738 | Completed | Phase 3 | Vincristine, Carboplatin, and Etoposide or Observation Only in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Retinoblastoma | December 2005 | September 30, 2020 |
| NCT00345865 | Completed | Phase 2 | Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma | August 24, 2005 | June 28, 2019 |
| NCT00349778 | Completed | Phase 2 | High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma | August 2006 | April 2010 |
| NCT00352027 | Completed | Phase 2 | Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma | July 20, 2006 | November 15, 2022 |
| NCT02523976 | Completed | Phase 2 | Dasatinib Combined With Chemotherapy in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia | August 1, 2015 | December 31, 2021 |
| NCT00354744 | Completed | Phase 3 | High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma | July 2006 | June 30, 2019 |
| NCT00357305 | Completed | Phase 1 | Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders | May 2006 | |
| NCT00357500 | Completed | Phase 2 | Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer | January 2005 | December 2013 |
| NCT00363415 | Completed | Phase 3 | Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer | August 2006 | June 2008 |
| NCT00365755 | Completed | Phase 3 | Combination Chemotherapy in Treating Young Patients Who Are Undergoing Surgery and an Autologous Bone Marrow Transplant for Disseminated Neuroblastoma | March 2008 | |
| NCT00369317 | Completed | Phase 3 | Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes | March 2007 | December 31, 2021 |
| NCT00372593 | Completed | Phase 3 | Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia | August 2006 | September 30, 2020 |
| NCT02512926 | Completed | Phase 1 | Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children | February 16, 2016 | November 7, 2023 |
| NCT00381680 | Completed | Phase 3 | Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia | March 2007 | |
| NCT00387699 | Completed | Phase 2 | Bevacizumab, Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | October 2006 | April 2014 |
| NCT00388349 | Completed | Phase 2 | Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease | September 2001 | September 2010 |
| NCT00388960 | Completed | Phase 2 | Study of Amrubicin With or Without Cisplatin Versus Etoposide-cisplatin for Extensive Stage Small Cell Lung Cancer | November 1, 2006 | December 1, 2010 |
| NCT00392834 | Completed | Phase 2 | Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma | September 2006 | July 2013 |
| NCT02504359 | Completed | Phase 1 | Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple Myeloma | July 20, 2015 | September 9, 2020 |
| NCT00398554 | Completed | Phase 2 | Combination Chemotherapy in Treating Young Male Patients With Hodgkin's Lymphoma | June 2005 | March 2013 |
| NCT00400946 | Completed | Phase 3 | Treatment of Acute Lymphoblastic Leukemia in Children | April 2005 | June 2019 |
| NCT00401609 | Completed | Phase 1/Phase 2 | G-Step: Gemcitabine Based Small-cell Lung Cancer Treatment in Elderly Patients | November 2000 | February 2009 |
| NCT00416598 | Completed | Phase 2 | Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia | November 15, 2006 | December 1, 2016 |
| NCT02502708 | Completed | Phase 1 | Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors | October 2015 | February 28, 2020 |
| NCT00416832 | Completed | Phase 2 | Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma | November 2002 | December 2005 |
| NCT02499770 | Completed | Phase 1/Phase 2 | Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC) | June 26, 2015 | February 22, 2019 |
| NCT00426101 | Completed | Phase 3 | Treatment Protocol for Hemophagocytic Lymphohistiocytosis 2004 | January 2004 | December 2017 |
| NCT00427791 | Completed | Phase 2 | Rituximab to the Preparative Regimen of Etoposide and Total Body Irradiation in Acute Lymphoblastic Leukemia | July 2005 | October 2009 |
| NCT00430118 | Completed | Phase 3 | Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia | July 2000 | January 2012 |
| NCT00432094 | Completed | Phase 2 | Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors | December 19, 2006 | March 2021 |
| NCT00439361 | Completed | Phase 1 | Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma | February 2007 | June 2012 |
| NCT00439556 | Completed | Phase 2 | Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell Transplant | February 13, 2007 | June 7, 2018 |
| NCT00450801 | Completed | Phase 2 | R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell Lymphoma | April 2004 | July 2015 |
| NCT00453154 | Completed | Phase 1/Phase 2 | Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer | March 15, 2007 | August 20, 2015 |
| NCT00453232 | Completed | Phase 2 | Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors | August 2004 | January 2009 |
| NCT00458848 | Completed | Phase 2 | Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia | October 2004 | March 2014 |
| NCT00472056 | Completed | Phase 2 | Rituximab in Addition to Autologous Transplantation With BEAM for Patients With Lymphoid Malignancies | March 2005 | June 2012 |
| NCT00477035 | Completed | Phase 1 | Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic Malignancies | May 2006 | March 2011 |
| NCT02489903 | Completed | Phase 2 | RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT) | June 2015 | December 6, 2021 |
| NCT00499343 | Completed | Phase 2 | G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients | January 2004 | October 2008 |
| NCT00499616 | Completed | Phase 3 | Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma | October 8, 2007 | June 30, 2021 |
| NCT02471911 | Completed | Phase 1 | KPT-330 Plus RICE for Relapsed/Refractory Aggressive B-Cell Lymphoma | December 11, 2015 | October 14, 2021 |
| NCT00504140 | Completed | Phase 2 | Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma | November 1996 | March 2009 |
| NCT00512252 | Completed | Phase 1/Phase 2 | AMD3100 Plus Mitoxantrone, Etoposide and Cytarabine in Acute Myeloid Leukemia | July 2007 | June 2010 |
| NCT00513162 | Completed | Phase 1 | Valproate and Etoposide for Patients With Neuronal Tumors and Brain Metastases | July 2007 | |
| NCT00513474 | Completed | Phase 1 | Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant | January 2008 | February 12, 2013 |
| NCT00514540 | Completed | Phase 2 | Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer | May 2006 | April 2013 |
| NCT00521014 | Completed | Phase 2 | GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma | October 2007 | July 2013 |
| NCT02432274 | Completed | Phase 1/Phase 2 | Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma | December 29, 2014 | July 20, 2022 |
| NCT00536601 | Completed | N/A | High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors | June 29, 2006 | July 9, 2018 |
| NCT00536978 | Completed | Phase 2 | Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid Malignancies | September 2007 | November 2010 |
| NCT02400281 | Completed | Phase 1/Phase 2 | Study of Crenolanib Combined With Chemotherapy in FLT3-mutated Acute Myeloid Leukemia Patients | September 2015 | July 15, 2020 |
| NCT02385110 | Completed | Phase 2 | Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis | September 23, 2015 | January 24, 2023 |
| NCT00544570 | Completed | N/A | High-Dose Chemotherapy in Treating Patients Undergoing Stem Cell Transplant for Recurrent or Refractory Hodgkin's Lymphoma | April 1998 | December 2007 |
| NCT00544596 | Completed | Phase 1 | R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer | September 2007 | |
| NCT02348216 | Completed | Phase 1/Phase 2 | Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma | April 21, 2015 | July 27, 2023 |
| NCT00551005 | Completed | Phase 1 | Etoposide and Celecoxib in Patients With Advanced Cancer | December 2001 | February 2012 |
| NCT00554463 | Completed | Phase 2 | G-CSF and Pegfilgrastim in Treating Neutropenia in Patients Undergoing Radiation Therapy and Chemotherapy for Limited Stage Small Cell Lung Cancer | January 2008 | August 3, 2011 |
| NCT00556127 | Completed | Phase 2 | Rituximab in Addition to Chemotherapy With Autologous Stem Cell Transplantation as Treatment Diffuse Large B-Cell Lymphoma | June 2002 | September 2006 |
| NCT00559104 | Completed | Phase 2 | Combination Chemotherapy With or Without Total-Body Irradiation Followed By Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma | October 1998 | July 2011 |
| NCT00562978 | Completed | Phase 1/Phase 2 | Yttrium Y 90 Ibritumomab Tiuxetan, Etoposide, Cyclophosphamide, and an AHSCT in Non-Hodgkin's Lymphoma Patients | May 16, 2000 | May 21, 2018 |
| NCT00567567 | Completed | Phase 3 | Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma | November 5, 2007 | March 31, 2022 |
| NCT00569985 | Completed | Phase 1 | Gene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related Lymphoma | June 2007 | November 12, 2019 |
| NCT00573690 | Completed | Phase 1 | Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid Tumors | September 2007 | February 2011 |
| NCT00577629 | Completed | Phase 2 | Chemotherapy With Monoclonal Antibody and Radioimmunotherapy for High-Risk B-Cell Non-Hodgkins Lymphoma | June 18, 2005 | November 3, 2016 |
| NCT00577993 | Completed | Phase 3 | Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients | March 16, 1998 | August 24, 2017 |
| NCT00589056 | Completed | Phase 1/Phase 2 | Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | June 2007 | March 2012 |
| NCT00589563 | Completed | Phase 2 | Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer | May 2007 | February 2012 |
| NCT00591630 | Completed | Phase 2 | Zevalin/BEAM/Rituximab vs BEAM/Rituximab With or Without Rituximab in Autologous Stem Cell Transplantation | November 14, 2007 | March 5, 2020 |
| NCT00598169 | Completed | Phase 1 | Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma | November 2007 | November 2014 |
| NCT00601718 | Completed | Phase 1/Phase 2 | Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell Lymphoma | December 2007 | |
| NCT00602771 | Completed | Phase 2 | Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid Leukemia | January 2008 | October 2011 |
| NCT00613457 | Completed | Phase 3 | Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia | September 2000 | July 2006 |
| NCT00613626 | Completed | Phase 2 | Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer | January 2008 | August 2015 |
| NCT00618501 | Completed | Phase 2 | Imatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | October 2005 | January 2009 |
| NCT00618813 | Completed | N/A | Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors | March 2008 | |
| NCT00621361 | Completed | Phase 1 | Phase I Safety and Tolerability Study of Cediranib (RECENTIN™, AZD2171) in Combination With Chemo in First Line Lung Cancer Patients | February 2008 | February 2012 |
| NCT00627354 | Completed | Phase 2 | Mitoxantrone, Etoposide, and Vinorelbine As Second-Line Therapy in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy | September 2006 | |
| NCT00634244 | Completed | Phase 2 | Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | October 2008 | October 2014 |
| NCT00653068 | Completed | Phase 3 | Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System | February 10, 2009 | March 31, 2024 |
| NCT02306291 | Completed | Phase 1/Phase 2 | Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML | March 2015 | May 2018 |
| NCT00662233 | Completed | Early Phase 1 | Combination Chemotherapy in Treating Patients With Sarcoma | October 1991 | October 21, 2013 |
| NCT00666484 | Completed | Phase 2 | Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma | March 2008 | September 2012 |
| NCT00666588 | Completed | Phase 2 | Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia | April 2008 | December 2012 |
| NCT00667342 | Completed | Phase 2 | A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma | June 3, 2008 | August 2017 |
| NCT00678327 | Completed | Phase 3 | Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma | August 29, 2008 | May 1, 2024 |
| NCT00686959 | Completed | Phase 3 | Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer | September 2008 | November 2014 |
| NCT00691015 | Completed | Phase 2 | Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant | May 2008 | April 2014 |
| NCT00691210 | Completed | Phase 1 | Phase I Vorinostat in Combination With Niacinamide and Etoposide for Lymphoid Malignancies | June 2008 | March 2015 |
| NCT00693719 | Completed | Phase 2 | Irinotecan and Etoposide in Treating Patients With Recurrent, Locally Advanced, or Metastatic Breast Cancer | August 2007 | May 2013 |
| NCT00695409 | Completed | Phase 2 | Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BEAM Followed By ASCT For Relapsed B-Cell Non-Hodgkin Lymphoma | March 18, 2008 | March 27, 2017 |
| NCT00697671 | Completed | Phase 1 | Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies | March 2007 | May 2013 |
| NCT00703820 | Completed | Phase 3 | Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia | August 4, 2008 | August 14, 2020 |
| NCT00720109 | Completed | Phase 2/Phase 3 | Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | July 14, 2008 | March 31, 2020 |
| NCT02299518 | Completed | Phase 1 | Selinexor and Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | May 18, 2015 | March 6, 2018 |
| NCT02298283 | Completed | Phase 2 | Brentuximab Vedotin as Consolidation Treatment in Patients With Stage I/II HL and PET Positivity After 2 Cycles of ABVD | April 2015 | July 9, 2020 |
| NCT02289690 | Completed | Phase 1/Phase 2 | Dose Escalation and Double-blind Study of Veliparib in Combination With Carboplatin and Etoposide in Treatment-naive Extensive Stage Disease Small Cell Lung Cancer | October 13, 2014 | April 17, 2019 |
| NCT00732498 | Completed | Phase 2 | Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Stage II, III, or IV Follicular NHL | May 15, 2006 | October 15, 2018 |
| NCT00742924 | Completed | Phase 1 | Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma | August 2008 | |
| NCT00749723 | Completed | Phase 2/Phase 3 | Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children | February 1, 2006 | January 31, 2016 |
| NCT00774046 | Completed | Phase 2 | High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML | December 2002 | March 2011 |
| NCT00776698 | Completed | Phase 1 | A Study of Avastin (Bevacizumab) in Combination With Thoracic Radiation and Chemotherapy in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer. | April 2009 | February 2010 |
| NCT00791154 | Completed | Phase 1/Phase 2 | QUILT-2.013: A Trial of AMG 479 or AMG 102 in Combination With Platinum-based Chemotherapy as First-Line Treatment for Extensive Stage Small Cell Lung Cancer | December 2008 | February 2013 |
| NCT00793845 | Completed | Phase 2 | Tandem High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients With High-risk Neuroblastoma | August 2008 | January 2018 |
| NCT02243436 | Completed | Phase 1/Phase 2 | Brentuximab Vedotin in Pre-transplant Induction and Consolidation for Relapsed or Refractory Hodgkin Lymphoma | November 11, 2014 | January 14, 2019 |
| NCT02219737 | Completed | Phase 1 | Ibrutinib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma | September 12, 2014 | May 11, 2017 |
| NCT02199184 | Completed | Phase 2 | Dose Adjusted EPOCH Regimen in Combination With Ofatumumab or Rituximab in Treating Patients With Newly Diagnosed or Relapsed or Refractory Burkitt Lymphoma or Relapsed or Refractory Acute Lymphoblastic Leukemia | January 14, 2015 | February 17, 2023 |
| NCT00822120 | Completed | Phase 2 | S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma | July 2009 | June 30, 2022 |
| NCT00826644 | Completed | Phase 3 | Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient | January 2009 | February 2013 |
| NCT02194049 | Completed | Phase 1 | Cisplatin, Etoposide and PI3K Inhibitor BKM120 in Treating Patients With Advanced Solid Tumors or Small Cell Lung Cancer | July 2014 | June 2016 |
| NCT00864318 | Completed | Phase 2 | Dose Intensification Study in Refractory Germ Cell Tumors With Relapse and Bad Prognosis | March 13, 2009 | October 5, 2020 |
| NCT00869752 | Completed | Phase 1/Phase 2 | MK-0646, Etoposide, and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer | December 16, 2009 | July 4, 2012 |
| NCT00887159 | Completed | Phase 2 | A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage | July 16, 2009 | November 15, 2016 |
| NCT00906945 | Completed | Phase 1/Phase 2 | Chemosensitization With Plerixafor Plus G-CSF in Acute Myeloid Leukemia | February 2011 | September 2015 |
| NCT02161692 | Completed | Phase 2 | Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors | December 1996 | April 2009 |
| NCT02157792 | Completed | Phase 1 | M6620 First in Human Study | December 10, 2012 | March 11, 2020 |
| NCT00926640 | Completed | Phase 1 | A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers | July 1, 2009 | April 20, 2018 |
| NCT00927875 | Completed | Phase 1 | A Study of BMS-833923 With Carboplatin and Etoposide Followed by BMS-833923 Alone in Subjects With Extensive-Stage Small Cell Lung Cancer | February 2010 | September 2012 |
| NCT00936936 | Completed | Phase 2 | High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors | June 2, 2009 | January 11, 2024 |
| NCT02130869 | Completed | Phase 1 | A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas | October 10, 2014 | December 20, 2017 |
| NCT00967369 | Completed | Phase 2 | Combination Chemotherapy With or Without Bortezomib in Treating Patients With Classical Hodgkin Lymphoma That Has Returned or Does Not Respond to Prior Treatment. | August 24, 2009 | May 2, 2018 |
| NCT00968760 | Completed | Phase 1 | CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies | June 20, 2011 | April 23, 2020 |
| NCT00973882 | Completed | Phase 2 | Carboplatin-Etoposide Combination in Hormone-Resistant Prostate Cancers | April 2005 | January 2010 |
| NCT02070458 | Completed | Phase 1 | Ixazomib, Mitoxantrone Hydrochloride, Etoposide, and Intermediate-Dose Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia | October 8, 2014 | August 15, 2017 |
| NCT02059239 | Completed | Phase 1/Phase 2 | Bendamustine Bridge to Autologous or Allogeneic Transplant for Relapsed/Refractory Lymphoma | June 4, 2014 | June 15, 2020 |
| NCT00984997 | Completed | Phase 2 | Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors | October 1993 | June 2015 |
| NCT00992446 | Completed | Phase 2 | Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma | September 2, 2010 | October 29, 2019 |
| NCT01000285 | Completed | Phase 1/Phase 2 | EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma | September 2010 | April 2016 |
| NCT01008462 | Completed | Phase 2 | Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia | March 18, 2010 | June 30, 2018 |
| NCT01013779 | Completed | Phase 2 | Merkel Positron Emission Tomography (PET) Protocol | December 2009 | June 2021 |
| NCT02029950 | Completed | Phase 1 | Pomalidomide After Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome | December 16, 2013 | May 13, 2020 |
| NCT02018861 | Completed | Phase 1/Phase 2 | A Phase 1/2, Open-Label, Dose Escalation, Safety and Tolerability Study of INCB050465 and Itacitinib in Subjects With Previously Treated B-Cell Malignancies (CITADEL-101) | September 22, 2016 | April 12, 2021 |
| NCT02017964 | Completed | Phase 2 | Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma | December 24, 2013 | December 31, 2022 |
| NCT01035463 | Completed | Phase 1/Phase 2 | Lenalidomide Therapy After Chemotherapy & Stem Cell Transplant in Treating Chemotherapy Resistan Non-Hodgkin Lymphoma | November 12, 2009 | July 27, 2018 |
| NCT01055314 | Completed | Phase 2 | Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma | January 2010 | June 2016 |
| NCT01059071 | Completed | Phase 1 | Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide | February 2010 | May 2015 |
| NCT01076231 | Completed | Phase 1/Phase 2 | Proton Beam Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery | January 2010 | May 24, 2018 |
| NCT01084759 | Completed | N/A | A Pilot Study of Parenteral Testosterone and Oral Etoposide as Therapy for Men With Castration Resistant Prostate Cancer | March 2010 | October 2014 |
| NCT01097057 | Completed | Phase 2 | Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Autologous Peripheral Blood Stem Cells | November 9, 2010 | December 26, 2017 |
| NCT01104025 | Completed | Phase 2 | Hybrid Immunotherapy for Hemophagocytic LymphoHistiocytosis | April 2010 | April 2016 |
| NCT01110135 | Completed | Phase 2 | Bendamustine Hydrochloride, Etoposide, Dexamethasone, and Filgrastim For Peripheral Blood Stem Cell Mobilization in Treating Patients With Refractory or Recurrent Lymphoma or Multiple Myeloma | August 2010 | |
| NCT01117441 | Completed | Phase 3 | International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia | June 2010 | December 31, 2021 |
| NCT01127009 | Completed | Phase 1 | Bortezomib, Mitoxantrone, Etoposide, and Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia | July 2010 | May 2014 |
| NCT01134861 | Completed | Phase 3 | Radiation Therapy Plus Chemotherapy in Treating Patients With Non-small Cell Lung Cancer | July 1994 | March 2012 |
| NCT01141712 | Completed | Phase 2 | Autologous Transplant in HIV Patients (BMT CTN 0803) | April 2010 | June 2016 |
| NCT01154439 | Completed | Phase 1 | Everolimus MICE-regimen in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia | October 2010 | September 15, 2015 |
| NCT01165112 | Completed | Phase 1/Phase 2 | Bendamustine Hydrochloride, Rituximab, Etoposide, and Carboplatin in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma or Hodgkin Lymphoma | September 2010 | June 2015 |
| NCT01169636 | Completed | Phase 1/Phase 2 | Panobinostat Plus Ifosfamide, Carboplatin, and Etoposide (ICE) Compared With ICE For Relapsed Hodgkin Lymphoma | January 31, 2011 | May 17, 2017 |
| NCT01174888 | Completed | Phase 1 | Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia | August 2010 | May 2016 |
| NCT01180322 | Completed | Phase 2 | Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With Azacitidine | November 2010 | October 2, 2016 |
| NCT01184898 | Completed | N/A | Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML) | July 2010 | February 2016 |
| NCT01193842 | Completed | Phase 1/Phase 2 | Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas | October 6, 2010 | May 19, 2022 |
| NCT01197560 | Completed | Phase 2/Phase 3 | Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) | September 2, 2010 | April 5, 2018 |
| NCT01987232 | Completed | Phase 1/Phase 2 | Phase 1b/2 Study of Carfilzomib, Carboplatin, and Etoposide in Patients With Previously Untreated Extensive Stage Small-cell Lung Cancer | November 5, 2013 | May 4, 2017 |
| NCT01979536 | Completed | Phase 2 | Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma | November 13, 2013 | March 31, 2024 |
| NCT01237808 | Completed | Phase 3 | Study of Low-Dose Cytarabine and Etoposide With or Without All-Trans Retinoic Acid in Older Patients Not Eligible for Intensive Chemotherapy With Acute Myeloid Leukemia and NPM1 Mutation | March 2011 | July 13, 2018 |
| NCT01251107 | Completed | Phase 3 | Study Comparing ABVD vs BEACOPP in Advanced Hodgkin's Lymphoma | March 2000 | November 2009 |
| NCT01959477 | Completed | Early Phase 1 | Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant | March 2014 | April 2015 |
| NCT01329900 | Completed | Phase 2 | Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas | August 22, 2011 | July 21, 2019 |
| NCT01331590 | Completed | Early Phase 1 | Disrupting the Bone Marrow Microenvironment With G-CSF in Acute Lymphoblastic Leukemia | July 2011 | November 2015 |
| NCT01336933 | Completed | Phase 2 | Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma | July 6, 2011 | December 28, 2016 |
| NCT01958372 | Completed | Phase 1 | Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer | August 2014 | November 11, 2019 |
| NCT01352117 | Completed | Phase 3 | Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's Sarcoma | November 18, 2011 | November 29, 2018 |
| NCT01921387 | Completed | Phase 1/Phase 2 | Radiolabeled Monoclonal Antibody and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With High-Risk Lymphoid Malignancies | October 9, 2013 | July 26, 2020 |
| NCT01900509 | Completed | Phase 1 | Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic Malignancies | August 2013 | May 2016 |
| NCT01411267 | Completed | Phase 1 | AC220 for Children With Relapsed/Refractory ALL or AML | September 1, 2011 | September 12, 2013 |
| NCT01439568 | Completed | Phase 2 | A Study of LY2510924 in Participants With Extensive-Stage Small Cell Lung Carcinoma | September 2011 | August 2016 |
| NCT01445535 | Completed | Phase 1 | Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell Lymphomas | January 13, 2009 | October 22, 2020 |
| NCT01450761 | Completed | Phase 3 | Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone | December 13, 2011 | May 17, 2017 |
| NCT01451515 | Completed | Phase 2 | NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma | May 25, 2012 | May 31, 2022 |
| NCT01458366 | Completed | Phase 1/Phase 2 | Phase I/II Study of Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide | November 9, 2011 | July 23, 2020 |
| NCT01481272 | Completed | Phase 2 | Ofatumumab With IVAC Salvage Chemotherapy in Diffuse Large B Cell Lymphoma Patients | November 2011 | December 2018 |
| NCT01505569 | Completed | N/A | Auto Transplant for High Risk or Relapsed Solid or CNS Tumors | October 20, 2011 | February 1, 2024 |
| NCT01526603 | Completed | N/A | High Dose Chemotherapy and Autologous Transplant for Neuroblastoma | March 28, 2012 | May 30, 2023 |
| NCT01849783 | Completed | Phase 2 | Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma | April 4, 2013 | September 30, 2020 |
| NCT01555541 | Completed | Phase 2 | Intensive Consolidation and Stem Cell Mobilization Therapy Followed by Autologous Stem Cell Transplantation in High-risk Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma | May 25, 2012 | July 1, 2021 |
| NCT01830777 | Completed | Phase 1 | Brentuximab Vedotin + Re-induction Chemotherapy for AML | May 2013 | May 2019 |
| NCT01569204 | Completed | Phase 2 | Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Classical Hodgkin Lymphoma | October 2012 | December 2017 |
| NCT01589159 | Completed | Phase 2 | A Phase Ⅱ Study of an All-Oral Combination of Low-dose Etoposide/Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines and/or Taxanes | January 2013 | December 2016 |
| NCT01590732 | Completed | Phase 1 | Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell Lymphoma | October 29, 2012 | May 2, 2018 |
| NCT01614197 | Completed | Phase 1 | A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma | July 3, 2015 | September 4, 2020 |
| NCT01642251 | Completed | Phase 1/Phase 2 | Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer | September 28, 2012 | July 2, 2018 |
| NCT01775475 | Completed | Phase 2 | Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma | September 15, 2016 | July 15, 2021 |
| NCT01681537 | Completed | Phase 1 | Lenalidomide Plus Chemotherapy for AML | September 2012 | December 2015 |
| NCT01700946 | Completed | Phase 2 | Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma | April 15, 2013 | July 24, 2021 |
| NCT01729845 | Completed | Phase 1/Phase 2 | Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes | December 20, 2012 | April 3, 2017 |
| NCT01760226 | Completed | Early Phase 1 | Dose Adjusted EPOCH-R, to Treat Mature B Cell Malignancies | January 2013 | December 2016 |
| NCT00000807 | Completed | Phase 2 | Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy | July 2000 | |
| NCT00002003 | Completed | Phase 2 | Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas | ||
| NCT00002461 | Completed | Phase 2 | Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma | April 1988 | July 1991 |
| NCT00002466 | Completed | Phase 2 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer | May 1990 | May 2005 |
| NCT00002471 | Completed | Phase 2 | Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma | February 1990 | January 2003 |
| NCT00002472 | Completed | Phase 2 | Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS Tumors | March 1991 | August 2005 |
| NCT00000660 | Completed | Phase 1 | Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma | July 1992 | |
| NCT06309732 | Completed | Phase 2 | GAMEC-II, Risk-adapted Protocol for Relapsed Germ Cell Tumours (GCT) | July 2006 | January 2014 |
| NCT06049966 | Completed | Phase 1 | Atezolizumab in Large Cell Neuroendocrine Carcinoma | March 1, 2018 | May 1, 2023 |
| NCT00002489 | Completed | Phase 2 | Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors | October 1991 | June 2002 |
| NCT00002494 | Completed | Phase 2 | Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia | May 1992 | January 2006 |
| NCT00002508 | Completed | Phase 1/Phase 2 | Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors | November 1990 | September 2001 |
| NCT00002509 | Completed | Phase 1/Phase 2 | High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer | November 1991 | December 2003 |
| NCT00002510 | Completed | Phase 1/Phase 2 | Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma | April 1992 | June 2001 |
| NCT00002514 | Completed | Phase 3 | Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission | May 7, 1993 | |
| NCT00002517 | Completed | Phase 3 | Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome | March 1993 | |
| NCT00002521 | Completed | Phase 2 | Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma | February 1993 | February 2000 |
| NCT00002522 | Completed | Phase 2 | Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma | February 1993 | February 2002 |
| NCT00002524 | Completed | Phase 2 | Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma | June 1993 | October 2005 |
| NCT05116007 | Completed | Phase 1 | Anti-PD-1 and VEGF Bispecific Antibody AK112 in Combination With Chemotherapy in Patients With ES-SCLC | March 29, 2021 | December 4, 2023 |
| NCT00002550 | Completed | Phase 3 | Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer | March 1994 | November 2013 |
| NCT00002552 | Completed | Phase 2 | Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma | October 1993 | October 2003 |
| NCT00002558 | Completed | Phase 1/Phase 2 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors | January 1994 | April 2009 |
| NCT00002565 | Completed | Phase 3 | Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma | May 25, 1994 | February 5, 2007 |
| NCT00002566 | Completed | Phase 3 | Combination Chemotherapy With Bone Marrow Transplantation in Treating Men With Germ Cell Tumors | February 1994 | December 2003 |
| NCT00002567 | Completed | Phase 2 | High-Dose Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia in Remission | March 1994 | November 2000 |
| NCT00002571 | Completed | Phase 2 | SWOG-9320 Combination Chemotherapy, Radiation Therapy, and Antiviral Therapy in Treating Patients With AIDS-Related Lymphoma | June 1994 | July 2011 |
| NCT00002588 | Completed | Phase 1 | Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia | August 1994 | January 2001 |
| NCT00002590 | Completed | Phase 2 | Combination Chemotherapy in Treating Children With Lymphoma | July 1994 | March 2007 |
| NCT00002596 | Completed | Phase 3 | Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors | September 1994 | July 2006 |
| NCT00002598 | Completed | Phase 2 | Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia | June 1994 | June 2004 |
| NCT00002610 | Completed | Phase 3 | Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors | January 1996 | February 2006 |
| NCT00002611 | Completed | Phase 3 | Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer | July 1995 | August 2003 |
| NCT00002634 | Completed | Phase 2 | Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma | February 1995 | September 2004 |
| NCT00002638 | Completed | Phase 2 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Relapsed Acute Lymphocytic Leukemia | March 1995 | March 2005 |
| NCT00002642 | Completed | Phase 2 | SWOG-9416: Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lung Cancer | April 1995 | July 2004 |
| NCT00002643 | Completed | Phase 2 | Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor | April 1995 | |
| NCT00002649 | Completed | Phase 3 | Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma | May 1995 | |
| NCT00002657 | Completed | Phase 2 | SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant | May 1995 | July 2011 |
| NCT05026593 | Completed | Phase 1 | A Study of IBI110 in Combination With Sintilimab and Chemotherapy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer | September 7, 2021 | June 26, 2023 |
| NCT00002665 | Completed | Phase 2 | SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia | July 1995 | December 2003 |
| NCT00002674 | Completed | Phase 2 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia | October 1994 | March 2000 |
| NCT00002675 | Completed | Phase 2 | Chemotherapy in Treating Patients With Retinoblastoma | May 1995 | January 2001 |
| NCT00002691 | Completed | Phase 2 | Combination Chemotherapy in Treating Pediatric Patients With Stage III or IV Non-Hodgkin's Lymphoma | August 1995 | June 2000 |
| NCT00002697 | Completed | Phase 2 | Combination Chemotherapy Plus Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma | September 1995 | June 2003 |
| NCT00002704 | Completed | Phase 2 | Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia | January 1996 | |
| NCT00002714 | Completed | Phase 2 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease | April 1995 | September 2001 |
| NCT00002715 | Completed | Phase 2 | Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma | April 1989 | October 2015 |
| NCT00002719 | Completed | Phase 3 | Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia | December 1995 | |
| NCT00002740 | Completed | Phase 1 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Followed by Surgery and/or Radiation Therapy in Treating Young Patients With Advanced Neuroblastoma | May 1996 | September 2005 |
| NCT00002756 | Completed | Phase 2 | Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia | June 1996 | March 2012 |
| NCT00002757 | Completed | Phase 3 | TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma | June 2001 | October 2009 |
| NCT00002766 | Completed | Phase 3 | Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma | March 1996 | September 2011 |
| NCT00002768 | Completed | Phase 2 | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second Remission | June 1996 | March 2009 |
| NCT00002785 | Completed | Phase 2 | Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia | July 1996 | March 2007 |
| NCT00002788 | Completed | Phase 1 | High-Dose Chemotherapy Followed by Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia | October 1995 | September 2002 |
| NCT00002798 | Completed | Phase 3 | Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome | August 1996 | |
| NCT00002800 | Completed | Phase 2 | Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome | July 1996 | March 2003 |
| NCT00002802 | Completed | Phase 3 | Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma | July 1990 | September 2003 |
| NCT00002805 | Completed | Phase 2 | Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome | August 1997 | June 2008 |
| NCT00002816 | Completed | Phase 3 | Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia | December 1996 | April 2006 |
| NCT00002822 | Completed | Phase 3 | Combination Chemotherapy Followed by Radiation Therapy in Patients With Small Cell Lung Cancer | March 1996 | November 2005 |
| NCT00002823 | Completed | Phase 3 | Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer | February 1995 | |
| NCT00002827 | Completed | Phase 3 | Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease | October 1996 | June 2008 |
| NCT00002829 | Completed | Phase 2 | Bone Marrow Transplantation in Treating Patients With Lymphoma | February 1994 | April 2002 |
| NCT00002836 | Completed | Phase 3 | Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer | September 26, 1995 | March 9, 2006 |
| NCT00002854 | Completed | Phase 1 | High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer | December 1994 | August 2015 |
| NCT04933617 | Completed | Phase 1 | Copanlisib With Dose-Adjusted EPOCH-R in Relapsed and Refractory Burkitt Lymphoma and Other High-Grade B-cell Lymphomas | March 24, 2022 | November 30, 2023 |
| NCT00002865 | Completed | Phase 2 | High-Intensity, Brief-Duration Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia | April 1995 | August 2001 |
| NCT00002868 | Completed | Phase 3 | Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia | November 20, 1997 | |
| NCT00002876 | Completed | Phase 2 | Etoposide Plus Cisplatin in Treating Patients With Recurrent Ependymomas | October 1991 | January 2005 |
| NCT00002898 | Completed | Phase 3 | Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma | January 1995 | December 2009 |
| NCT04878016 | Completed | Phase 3 | A Study of Carboplatin Plus Etoposide With or Without ZKAB001 (Anti-PD-L1 Antibody) in Patients With ES-SCLC | July 15, 2021 | October 13, 2023 |
| NCT00002912 | Completed | Phase 1 | Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia | January 1997 | |
| NCT00002925 | Completed | Phase 1/Phase 2 | Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia | February 1997 | June 2010 |
| NCT04778410 | Completed | Phase 2 | Study of Magrolimab Combinations in Participants With Myeloid Malignancies | June 28, 2021 | March 1, 2024 |
| NCT00002931 | Completed | Phase 2 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer | February 1997 | December 2014 |
| NCT00002936 | Completed | Phase 1 | Altretamine and Etoposide in Treating Patients With HIV-Related Cancer | July 1996 | |
| NCT00002941 | Completed | Phase 2 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's Lymphoma | April 1998 | March 2007 |
| NCT00002943 | Completed | Phase 2 | Carboplatin, Etoposide, Cyclophosphamide, and Autologous Bone Marrow Transplantation in Patients With Relapsed or Refractory Cancer | February 1993 | August 2007 |
| NCT00002945 | Completed | Phase 3 | High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia | December 1996 | August 2011 |
| NCT00002974 | Completed | Phase 2 | Whole-Body Hyperthermia Plus Chemotherapy in Treating Patients With Advanced Sarcoma | July 1996 | April 2003 |
| NCT00002982 | Completed | Phase 2 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's Lymphoma | January 1997 | October 2005 |
| NCT00003052 | Completed | Phase 3 | Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma | July 1997 | June 2010 |
| NCT00003084 | Completed | Phase 2 | Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer | December 1997 | November 2002 |
| NCT00003093 | Completed | Phase 3 | Combination Chemotherapy in Treating Children With Neuroblastoma | March 1988 | January 2011 |
| NCT04712903 | Completed | Phase 3 | Durvalumab Plus Chemotherapy in Untreated Patients With Extensive-Stage Small Cell Lung Cancer | December 16, 2020 | June 21, 2023 |
| NCT00003114 | Completed | Phase 2 | Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's Disease | July 1997 | February 2003 |
| NCT00003119 | Completed | Phase 3 | Surgery in Treating Children With Neuroblastoma | March 1998 | March 2006 |
| NCT00003141 | Completed | Phase 1 | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors | March 1998 | October 2011 |
| NCT00003158 | Completed | Phase 2 | S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung Cancer | February 1998 | December 2007 |
| NCT00003190 | Completed | Phase 3 | Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid Leukemia | January 1998 | |
| NCT00003215 | Completed | Phase 3 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma | April 1997 | March 2004 |
| NCT00003243 | Completed | Phase 1 | Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer | January 1998 | |
| NCT00003269 | Completed | Phase 2 | Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors | February 1998 | January 2001 |
| NCT04631029 | Completed | Phase 1 | Testing the Addition of an Anti-cancer Drug, Entinostat, to the Usual Chemotherapy and Immunotherapy Treatment (Atezolizumab, Carboplatin and Etoposide) for Previously Untreated Aggressive Lung Cancer That Has Spread | April 27, 2021 | July 11, 2023 |
| NCT00003299 | Completed | Phase 3 | Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer | April 1998 | January 2006 |
| NCT00003309 | Completed | Phase 2 | Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With Brain Cancer | May 4, 1999 | |
| NCT00003364 | Completed | Phase 3 | Radiation Therapy Plus Combination Chemotherapy In Treating Patients With Limited Stage Small Cell Lung Cancer | January 1993 | August 2006 |
| NCT00003389 | Completed | Phase 3 | Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma | June 17, 1999 | May 2016 |
| NCT00003397 | Completed | Phase 2 | Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma | September 1998 | December 2002 |
| NCT00003399 | Completed | Phase 2 | Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma | September 1998 | September 2002 |
| NCT00003401 | Completed | Phase 2 | Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma | January 1999 | September 2002 |
| NCT00003402 | Completed | Phase 2 | Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia | January 1999 | December 2002 |
| NCT00003421 | Completed | Phase 3 | Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease | June 1998 | November 2005 |
| NCT00003436 | Completed | Phase 3 | Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia | July 1998 | December 2005 |
| NCT00003541 | Completed | Phase 1/Phase 2 | Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma | June 1998 | July 2006 |
| NCT00003573 | Completed | Phase 2 | Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma | November 1998 | March 2008 |
| NCT00003575 | Completed | Phase 2 | Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's Lymphoma | January 1999 | |
| NCT04154189 | Completed | Phase 2 | A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma | March 23, 2020 | August 17, 2023 |
| NCT00003597 | Completed | Phase 1 | Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors | November 1998 | September 2005 |
| NCT00003606 | Completed | Phase 3 | Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell Lung Cancer | March 1996 | June 2001 |
| NCT00003619 | Completed | Phase 1/Phase 2 | Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia | February 1998 | April 2004 |
| NCT00003621 | Completed | Phase 2 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Anaplastic Astrocytoma | February 1999 | July 2005 |
| NCT00003625 | Completed | Phase 1 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma | December 1998 | April 2006 |
| NCT00003631 | Completed | Phase 2 | Chemotherapy Plus Radiation Therapy in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma | August 1998 | |
| NCT00003632 | Completed | Phase 2 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Central Nervous System Lymphoma | September 1998 | |
| NCT00003650 | Completed | Phase 3 | Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma | February 1997 | November 2013 |
| NCT00003657 | Completed | Phase 2 | High-dose ICE With Amifostine | July 1998 | June 2002 |
| NCT06418594 | Not yet recruiting | Phase 2 | Adebrelimab Plus Apatinib and Etoposide for the Treatment of HER2-Negative Breast Cancer Brain Metastasis | May 15, 2024 | December 31, 2026 |
| NCT03628131 | Not yet recruiting | Phase 1/Phase 2 | Combination Chemotherapy With Pazopanib in Children and Adolescents With Relapsed/Refractory Solid Tumors | October 2018 | July 2025 |
| NCT03669783 | Not yet recruiting | Phase 3 | Clinical Trial for Patients With a Stage IV Childhood Renal Tumor, Comparing Upfront Vincristine, Actinomycin-D and Doxorubicin (Standard Arm) With Upfront Vincristine, Carboplatin and Etoposide (Experimental Arm) | January 1, 2019 | January 1, 2027 |
| NCT04683198 | Not yet recruiting | Phase 2 | Camrelizumab Combined With Apatinib ,Carboplatin and Etoposide in Participants With ES-SCLC | April 1, 2021 | June 30, 2024 |
| NCT05006664 | Not yet recruiting | Phase 2 | Brentuximab Vedotin in Combination With CHEP in Patient With PTCL | October 2021 | October 2024 |
| NCT05142865 | Not yet recruiting | Phase 2 | Camrelizumab Combined With Chemotherapy and Apatinib for Extrapulmonary Neuroendocrine Carcinomas | January 14, 2022 | December 31, 2024 |
| NCT05590572 | Not yet recruiting | Phase 1/Phase 2 | A Study of Sulfatinib on Relapsed or Refractory Drug Resistant Osteosarcoma | January 2023 | December 2027 |
| NCT05776407 | Not yet recruiting | Phase 1/Phase 2 | Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell Lymphoma | May 2023 | November 2024 |
| NCT05784987 | Not yet recruiting | N/A | R-MINE+X in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma | April 15, 2023 | January 1, 2025 |
| NCT05863845 | Not yet recruiting | N/A | Efficacy and Safety of Venetoclax Combined With BEAM Pretreatment in Autologous Transplantation for DLBCL | June 1, 2023 | November 30, 2025 |
| NCT05991388 | Not yet recruiting | Phase 2/Phase 3 | A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma | May 2024 | May 2033 |
| NCT06160791 | Not yet recruiting | Phase 2 | Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH) | February 1, 2024 | May 31, 2027 |
| NCT06249191 | Not yet recruiting | Phase 1/Phase 2 | Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma | May 31, 2024 | April 1, 2027 |
| NCT06362252 | Not yet recruiting | Phase 1/Phase 2 | A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03) | June 17, 2024 | December 30, 2026 |
| NCT06368817 | Not yet recruiting | Phase 2 | A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma | July 12, 2024 | November 4, 2033 |
| NCT06377540 | Not yet recruiting | Phase 2 | MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma | August 1, 2024 | September 1, 2027 |
| NCT06401330 | Not yet recruiting | Phase 3 | A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT) | June 12, 2024 | February 13, 2031 |
| NCT06406465 | Not yet recruiting | Phase 2 | A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity | June 23, 2024 | July 30, 2028 |
| NCT05068232 | Recruiting | Phase 2 | Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES) | August 19, 2022 | October 1, 2027 |
| NCT02861573 | Recruiting | Phase 1/Phase 2 | Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365) | November 17, 2016 | October 22, 2027 |
| NCT05019716 | Recruiting | Phase 1/Phase 2 | Testing the Safety and Efficacy of the Addition of A New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Etoposide and Cisplatin) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma | July 13, 2022 | December 1, 2024 |
| NCT02870907 | Recruiting | Phase 2 | Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009) | March 2010 | September 2030 |
| NCT06217757 | Recruiting | Phase 1/Phase 2 | Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLC | April 18, 2024 | March 20, 2027 |
| NCT06110572 | Recruiting | Phase 1/Phase 2 | Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation | July 31, 2024 | June 30, 2028 |
| NCT06091124 | Recruiting | Phase 2 | Neoadjuvant Adebrelimab Plus Etoposide and Cisplatin in Neuroendocrine Bladder Carcinoma | November 16, 2023 | December 31, 2026 |
| NCT02905110 | Recruiting | Early Phase 1 | Methotrexate and Etoposide Infusions Into the Fourth Ventricle in Children With Recurrent Posterior Fossa Brain Tumors | October 2016 | November 2025 |
| NCT04981899 | Recruiting | Phase 1/Phase 2 | A Study of Safety and Efficacy of PET-adapted Treatment With Nivolumab at the Fixed Dose 40 mg, Ifosfamide, Carboplatin, Etoposide (NICE-40) in Patients With Relapsed/Refractory Hodgkin Lymphoma | March 1, 2021 | October 1, 2024 |
| NCT05765825 | Recruiting | Phase 2 | Study of Low-Dose Radiotherapy Concurrent Cisplatin/Carboplatin Plus Etoposide With Serplulimab for Patients With ES-SCLC | March 7, 2023 | December 2025 |
| NCT04947501 | Recruiting | Early Phase 1 | A Study of N9 Chemotherapy in Children With Neuroblastoma | June 22, 2021 | June 22, 2025 |
| NCT04923776 | Recruiting | Phase 2 | Liver Directed RT + Chemo-immunotherapy for ES-SCLC | September 20, 2021 | February 2025 |
| NCT02429687 | Recruiting | Phase 3 | TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors | April 2015 | May 2030 |
| NCT02429700 | Recruiting | Phase 3 | TC or BEP in Treating Patients With Ovarian Malignant Sex Cord-Stromal Tumors | April 2015 | May 2030 |
| NCT04871607 | Recruiting | Phase 2 | Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma | November 2, 2021 | October 2, 2027 |
| NCT01356290 | Recruiting | Phase 2 | Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma and ATRT | April 2014 | April 2026 |
| NCT04833114 | Recruiting | Phase 3 | Polatuzumab Vedotin Plus Rituximab, Ifosfamide, Carboplatin and Etoposide (Pola-R-ICE) Versus R-ICE Alone in Second Line Treatment of Diffuse Large B-cell Lymphoma (DLBCL) | April 30, 2021 | December 31, 2025 |
| NCT03007147 | Recruiting | Phase 3 | Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia | August 8, 2017 | September 30, 2027 |
| NCT02436707 | Recruiting | Phase 2 | Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma | October 27, 2015 | December 31, 2026 |
| NCT06077500 | Recruiting | Phase 1 | DAREONᵀᴹ-8: A Study to Test How Well Different Doses of BI 764532 in Addition to Standard of Care Are Tolerated by People With Advanced Small Cell Lung Cancer | January 11, 2024 | June 25, 2026 |
| NCT04804007 | Recruiting | Phase 2 | Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT | March 3, 2021 | December 2028 |
| NCT04803201 | Recruiting | Phase 2 | Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma | July 30, 2021 | January 1, 2026 |
| NCT05903092 | Recruiting | Phase 2 | MOnaliZumab in Combination With durvAlumab (MEDI4736) Plus Platinum-based chemotheRapy for First-line Treatment of Extensive Stage Small Cell Lung Cancer | September 26, 2023 | June 30, 2025 |
| NCT01887340 | Recruiting | Phase 2 | Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma | June 2013 | June 2026 |
| NCT04765098 | Recruiting | Phase 2 | Tamoxifen Versus Etoposide After First Recurrence in GBM Patients | January 28, 2022 | December 2026 |
| NCT06262438 | Recruiting | Phase 2 | CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients | February 6, 2024 | June 2032 |
| NCT01704716 | Recruiting | Phase 3 | High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN) | February 2002 | September 2026 |
| NCT05844150 | Recruiting | Phase 2/Phase 3 | A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With ES-SCLC | June 1, 2023 | December 2025 |
| NCT04728230 | Recruiting | Phase 1/Phase 2 | Olaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO Trial | January 5, 2021 | December 31, 2025 |
| NCT04702880 | Recruiting | Phase 2 | A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer | March 17, 2021 | December 31, 2025 |
| NCT04699838 | Recruiting | Phase 2 | Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung Cancer | April 20, 2021 | September 2024 |
| NCT03067181 | Recruiting | Phase 3 | Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors | May 25, 2017 | June 30, 2027 |
| NCT04696575 | Recruiting | Phase 2 | Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer | July 2, 2021 | July 1, 2026 |
| NCT05675410 | Recruiting | Phase 3 | A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab | May 11, 2023 | April 28, 2031 |
| NCT04684368 | Recruiting | Phase 2 | A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT | July 13, 2021 | December 21, 2029 |
| NCT06177925 | Recruiting | Phase 2 | A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC | December 10, 2023 | September 30, 2026 |
| NCT05664971 | Recruiting | Phase 1/Phase 2 | JS004 Combined With Toripalimab and With Standard Chemotherapy Treat Patients With Advanced Lung Cancer | February 9, 2023 | November 17, 2024 |
| NCT03117010 | Recruiting | Prospective Cohort for Adult Hemophagocytosis | January 1, 2017 | December 31, 2024 | |
| NCT04679012 | Recruiting | Phase 2 | Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's Transformation | September 24, 2021 | September 2026 |
| NCT04638790 | Recruiting | Phase 3 | First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1) | February 1, 2020 | December 31, 2026 |
| NCT03125642 | Recruiting | Phase 2 | Auto Stem Cell Transplant for Lymphoma Patients | April 20, 2017 | April 30, 2026 |
| NCT04585893 | Recruiting | Phase 2 | Safety and Efficacy of Rituximab for Treatment of Multicentric Castleman Disease in Malawi | June 22, 2021 | August 2026 |
| NCT03136146 | Recruiting | Phase 2 | Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia | August 9, 2017 | August 1, 2026 |
| NCT04560972 | Recruiting | Phase 1 | LB-100, Carboplatin, Etoposide, and Atezolizumab for the Treatment of Untreated Extensive-Stage Small Cell Lung Cancer | May 28, 2021 | March 9, 2026 |
| NCT04551131 | Recruiting | Phase 1/Phase 2 | Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis | July 13, 2021 | August 2026 |
| NCT05624996 | Recruiting | Phase 3 | Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-small Cell Lung Cancer | May 10, 2023 | October 15, 2036 |
| NCT03206671 | Recruiting | Phase 3 | Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents | August 3, 2017 | August 2024 |
| NCT03220022 | Recruiting | Phase 1 | Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas | March 16, 2018 | June 20, 2025 |
| NCT05106296 | Recruiting | Phase 1 | Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer | February 8, 2022 | September 2026 |
| NCT05058651 | Recruiting | Phase 2/Phase 3 | Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung | June 28, 2022 | October 1, 2028 |
| NCT04543890 | Recruiting | Phase 2 | A Prospective Study Comparing Two Radiotherapy Dose/Fraction and Omitting CTVs of the Primary Tumor in Limited SCLC | May 1, 2018 | June 1, 2025 |
| NCT04530487 | Recruiting | Phase 2 | Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults | August 19, 2020 | May 9, 2025 |
| NCT04469530 | Recruiting | Phase 2 | Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors | September 16, 2020 | September 2025 |
| NCT04432714 | Recruiting | Phase 1/Phase 2 | Lenalidomide in Combination With R-DA-EPOCH in Patients With Untreated DLBCL With MYC Rearrangement | June 9, 2020 | December 31, 2026 |
| NCT04322318 | Recruiting | Phase 2 | A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT | October 19, 2020 | July 1, 2027 |
| NCT05832320 | Recruiting | N/A | Optimum Induction Therapy of Low-risk APL | January 1, 2023 | December 31, 2024 |
| NCT03418038 | Recruiting | Phase 2 | Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia | March 23, 2018 | March 2026 |
| NCT03420963 | Recruiting | Phase 1 | Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors | August 31, 2018 | December 1, 2027 |
| NCT04301076 | Recruiting | Phase 1 | Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATL) | August 31, 2021 | December 31, 2025 |
| NCT04221035 | Recruiting | Phase 3 | High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN) | November 5, 2019 | November 2032 |
| NCT04177004 | Recruiting | Phase 1 | Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant | April 30, 2021 | December 31, 2024 |
| NCT05605899 | Recruiting | Phase 3 | Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma | February 10, 2023 | March 2031 |
| NCT04139304 | Recruiting | Early Phase 1 | A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma | May 24, 2021 | August 2027 |
| NCT04129710 | Recruiting | Phase 2 | A Trial to Compare Ibrutinib Versus Lenalidomide in Combination With MRE-chemotherapy for Adult Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) | January 1, 2020 | December 31, 2025 |
| NCT04049669 | Recruiting | Phase 2 | Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG | October 2, 2019 | October 2, 2027 |
| NCT04044222 | Recruiting | Phase 3 | A Study to Evaluate the Efficacy and Safety of a Sintilimab Plus ICE Regimen Versus ICE Regimen in Classic Hodgkin's Lymphoma Patients (cHL) Who Have Failed First-line Standard Chemotherapy | October 21, 2019 | December 31, 2024 |
| NCT03926624 | Recruiting | Phase 3 | Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage | November 22, 2019 | December 2022 |
| NCT03837873 | Recruiting | Phase 2 | DLCL002 Protocol for Patients With High Risk Aggressive B-cell Lymphoma | January 21, 2019 | September 1, 2024 |
| NCT03570983 | Recruiting | Phase 2 | A Trial Comparing Single Agent Melphalan to Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) as a Preparative Regimen for Patients With Multiple Myeloma Undergoing High Dose Therapy Followed by Autologous Stem Cell Reinfusion | September 5, 2018 | December 2024 |
| NCT03793478 | Recruiting | Phase 1/Phase 2 | Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood | August 15, 2018 | May 1, 2027 |
| NCT03755804 | Recruiting | Phase 2 | Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17 | December 12, 2018 | July 1, 2028 |
| NCT03736616 | Recruiting | Phase 2 | Acalabrutinib Plus RICE for Relapsed/Refractory DLBCL | August 16, 2019 | September 2023 |
| NCT03583710 | Recruiting | Phase 3 | Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence | August 20, 2018 | January 22, 2025 |
| NCT05821088 | Recruiting | Phase 2 | Tafasitamab and Lenalidomide Followed by Tafasitamab and ICE as Salvage Therapy for Transplant Eligible Patients With Relapsed/ Refractory Large B-Cell Lymphoma | June 29, 2023 | December 31, 2025 |
| NCT03591510 | Recruiting | Phase 2 | A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML | March 13, 2019 | February 15, 2029 |
| NCT03719105 | Recruiting | Early Phase 1 | Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma | March 1, 2019 | December 31, 2026 |
| NCT06372626 | Recruiting | Phase 1/Phase 2 | Study of ZG005 in Combination With Etoposide and Cisplatin in Participants With Advanced Neuroendocrine Carcinoma. | May 30, 2024 | August 2026 |
| NCT03643276 | Recruiting | Phase 3 | Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017 | July 15, 2018 | July 14, 2028 |
| NCT06172296 | Recruiting | Phase 3 | Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma | April 19, 2024 | December 31, 2029 |
| NCT05600686 | Recruiting | Phase 2 | Loncastuximab Tesirine and Rituximab Followed by DA-EPOCH-R for Treating Patients With High-Risk Diffuse Large B-cell Lymphoma | May 24, 2023 | February 1, 2028 |
| NCT05595460 | Recruiting | Phase 1 | Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC | October 10, 2022 | December 2026 |
| NCT05594290 | Recruiting | Phase 2 | Chemo-immunotherapy in Patients With Resectable Merkel Cell Carcinoma Prior to Surgery | December 7, 2022 | November 2026 |
| NCT06140966 | Recruiting | Phase 2 | Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, Ultra High-risk, Newly Diagnosed Multiple Myeloma | October 20, 2023 | October 20, 2027 |
| NCT06230224 | Recruiting | Phase 3 | A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma | February 15, 2024 | July 6, 2027 |
| NCT02574728 | Recruiting | Phase 2 | Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors | June 2015 | February 2025 |
| NCT05546060 | Recruiting | Phase 1 | Efficacy and Safety of Venetoclax Combined With Dexamethasone and Etoposide in HLH | July 1, 2022 | October 1, 2025 |
| NCT05536154 | Recruiting | N/A | Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies | November 1, 2022 | October 2024 |
| NCT06132113 | Recruiting | Phase 1 | DAREON™-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine Cancers | December 20, 2023 | December 1, 2025 |
| NCT05535166 | Recruiting | Phase 2 | Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma | December 20, 2022 | July 2035 |
| NCT02605421 | Recruiting | Phase 2 | Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma | June 2016 | July 2025 |
| NCT05533775 | Recruiting | Phase 1/Phase 2 | A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma | November 16, 2022 | October 15, 2027 |
| NCT05517213 | Recruiting | N/A | High-dose Chemotherapy+G-CSF in Peripheral Blood Stem Cell Mobilization in Patients With Multiple Myeloma | February 1, 2022 | October 1, 2025 |
| NCT05510089 | Recruiting | N/A | Etoposide+Cytarabine+PEG-rhG-CSF for Hematopoietic Stem Cell Mobilization in Patients With Hematological Malignancies | September 1, 2022 | December 31, 2024 |
| NCT05504291 | Recruiting | Phase 2 | A Study to Give Treatment Inside the Eye to Treat Retinoblastoma | November 4, 2022 | December 31, 2026 |
| NCT06140407 | Recruiting | Phase 2 | Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung Cancer | May 8, 2024 | May 31, 2029 |
| NCT06039371 | Recruiting | Phase 2 | Supraphysiological Androgen to Enhance Chemotherapy Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study | May 21, 2024 | December 31, 2027 |
| NCT02633514 | Recruiting | Phase 3 | Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma | December 1, 2023 | December 2026 |
| NCT05491304 | Recruiting | Phase 4 | Cytokine Guided Risk Stratification and Treatment in Pediatric Hemophagocytic Lymphohistiocytosis | September 1, 2022 | December 31, 2025 |
| NCT05466318 | Recruiting | Phase 3 | ChiCGB vs BEAM in High-risk or R/R Lymphomas | July 1, 2022 | December 30, 2025 |
| NCT02639650 | Recruiting | Phase 3 | Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor | March 1, 2016 | March 1, 2026 |
| NCT05815160 | Recruiting | Phase 1 | Debio 0123 in Combination With Carboplatin and Etoposide in Adult Participants With Small Cell Lung Cancer That Recurred or Progressed After Previous Standard Platinum-Based Therapy | May 2, 2023 | April 2026 |
| NCT05453500 | Recruiting | Phase 2 | Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia | March 27, 2023 | September 1, 2030 |
| NCT05389423 | Recruiting | Phase 1 | Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas | June 27, 2023 | June 1, 2032 |
| NCT05384821 | Recruiting | Phase 1/Phase 2 | Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906) | September 14, 2022 | October 2028 |
| NCT05800587 | Recruiting | Phase 2 | Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer | February 22, 2023 | August 1, 2029 |
| NCT02705508 | Recruiting | Phase 2 | PEG-ASP, Etoposide and Gemcitabine for Natural Killer/T Lymphoma | February 2016 | December 2023 |
| NCT06256237 | Recruiting | Phase 2 | Neoadjuvant Therapy With Toripalimab and JS004 Combined With Etoposide and Platinum Chemotherapy for Limited-stage Small Cell Lung Cancer : A Phase 2 Trial | April 1, 2024 | January 31, 2032 |
| NCT05384015 | Recruiting | Phase 2 | Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung Cancer | November 7, 2022 | July 30, 2027 |
| NCT05364424 | Recruiting | Phase 1 | A Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Glofitamab in Combination With Rituximab Plus Ifosfamide, Carboplatin Etoposide Phosphate in Participants With Relapsed/Refractory Transplant or CAR-T Therapy Eligible Diffuse B-Cell Lymphoma | November 4, 2022 | December 31, 2024 |
| NCT06030258 | Recruiting | Phase 1/Phase 2 | IN10018 Combination Therapy in Treatment-naïve ES-SCLC | October 30, 2023 | October 21, 2025 |
| NCT05361395 | Recruiting | Phase 1 | First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC) | August 24, 2022 | January 1, 2027 |
| NCT02094794 | Recruiting | Phase 2 | Total Marrow and Lymphoid Irradiation and Chemotherapy Before DSCT in Treating Patients With High-Risk ALL or AML | May 12, 2014 | February 28, 2025 |
| NCT05312671 | Recruiting | Phase 2 | Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer | June 27, 2022 | June 2027 |
| NCT05955261 | Recruiting | Phase 2 | A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia | July 25, 2023 | March 2034 |
| NCT05298423 | Recruiting | Phase 3 | Study of Pembrolizumab/Vibostolimab (MK-7684A) in Combination With Concurrent Chemoradiotherapy Followed by Pembrolizumab/Vibostolimab Versus Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With Stage III Non-small Cell Lung Cancer (MK-7684A-006/KEYVIBE-006) | May 3, 2022 | September 4, 2029 |
| NCT05294055 | Recruiting | Phase 2 | Mecapegfilgrastim With Chemotherapy for Peripheral Blood Stem Cell Mobilization in MM and Lymphoma | April 26, 2022 | September 30, 2024 |
| NCT05270057 | Recruiting | Phase 1 | Loncastuximab Tesirine in Combination With DA-EPOCH-R in Patients With Previously Untreated Aggressive B-cell Lymphoid Malignancies | January 26, 2023 | May 2026 |
| NCT05221645 | Recruiting | Phase 2 | Pembrolizumab in Combination With R-ICE Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma | June 27, 2022 | December 1, 2025 |
| NCT02372409 | Recruiting | Phase 2 | Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors | August 14, 2015 | August 31, 2030 |
| NCT05936086 | Recruiting | N/A | A Randomized Controlled Study of High-dose Cyclophosphamide Induction Therapy in Adult Patients With HLH | April 20, 2023 | May 20, 2027 |
| NCT02797717 | Recruiting | N/A | Treatment for Classical Hodgkin Lymphoma in Children and Adolescents | November 2015 | December 2027 |
| NCT06221683 | Recruiting | Phase 2 | Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML | March 2024 | December 2029 |
| NCT02393157 | Recruiting | Phase 2 | Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL | August 21, 2015 | December 2024 |
| NCT05142696 | Recruiting | Phase 1/Phase 2 | A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab | July 13, 2022 | May 3, 2028 |
| NCT04546399 | Suspended | Phase 2 | A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL) | December 4, 2020 | June 30, 2028 |
| NCT04231877 | Suspended | Phase 1 | Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Untreated Aggressive Large B-cell Lymphoma | October 27, 2020 | December 1, 2031 |
| NCT00072280 | Terminated | Phase 2 | Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma | November 2004 | March 2008 |
| NCT01411098 | Terminated | Phase 1 | Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery | October 2011 | |
| NCT01904643 | Terminated | Phase 1 | Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | February 2014 | July 18, 2015 |
| NCT01408043 | Terminated | N/A | Etoposide, Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients With Non-Hodgkin Lymphoma | October 2011 | May 2016 |
| NCT01390584 | Terminated | Phase 2 | Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma | May 24, 2013 | May 18, 2018 |
| NCT01342887 | Terminated | Phase 1/Phase 2 | Cyclosporine, Pravastatin Sodium, Etoposide, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | April 2011 | March 2012 |
| NCT01260714 | Terminated | Phase 1 | Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid Leukemia | December 2010 | June 2015 |
| NCT01258634 | Terminated | Phase 1 | A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response | July 2010 | November 2011 |
| NCT01222572 | Terminated | Phase 1/Phase 2 | Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer | December 2010 | October 2012 |
| NCT01220297 | Terminated | Phase 2 | Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCT | August 2006 | August 2011 |
| NCT01032070 | Terminated | Phase 2 | Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma | September 27, 2010 | November 26, 2012 |
| NCT01027923 | Terminated | Phase 1 | IV Plerixafor With Mitoxantrone Etoposide and Cytarabine for Acute Myeloid Leukemia (AML) | May 2010 | September 2011 |
| NCT01014767 | Terminated | Phase 3 | Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors | November 2009 | January 2014 |
| NCT02043587 | Terminated | Phase 2 | Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma | January 2014 | April 14, 2022 |
| NCT00981799 | Terminated | Phase 1/Phase 2 | Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL | June 2010 | July 18, 2016 |
| NCT00977561 | Terminated | Phase 2 | A Study Of Cisplatin (Or Carboplatin) And Etoposide With Or Without Figitumumab (CP-751,871) In Patients With Extensive-Stage Small Cell Lung Cancer | April 2010 | October 2011 |
| NCT00960063 | Terminated | Phase 1 | A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006) | November 11, 2009 | December 22, 2010 |
| NCT02116959 | Terminated | Phase 1 | Alternating Systemic Chemotherapy and Intra-Arterial Melphalan (IAM) Chemotherapy in Children With Intra-Ocular Retinoblastoma | July 23, 2014 | May 25, 2019 |
| NCT00939653 | Terminated | Phase 2 | T2007-002 Clofarabine, Etoposide, Cyclophosphamide in Relapsed Acute Myelogenous Leukemia (AML) | July 10, 2009 | July 15, 2011 |
| NCT00924209 | Terminated | Phase 2 | A Phase II Study of Neo-Adjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung Cancer | March 2009 | September 2011 |
| NCT00920153 | Terminated | Phase 3 | Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma | May 2008 | March 2016 |
| NCT00882076 | Terminated | Phase 1 | Clofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute Leukemias | March 2009 | March 2011 |
| NCT00811993 | Terminated | Phase 1 | A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors | February 2009 | December 2012 |
| NCT00810017 | Terminated | Phase 2 | Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast Cancer | February 2009 | June 2010 |
| NCT00809341 | Terminated | Phase 2 | R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma | January 2009 | April 2014 |
| NCT00808899 | Terminated | Phase 2 | Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk Neuroblastoma | December 2008 | July 2009 |
| NCT00807755 | Terminated | Phase 1 | Everolimus, Carboplatin, and Etoposide in Treating Patients With Small Cell Lung Cancer or Other Advanced Solid Tumors | March 2009 | December 2011 |
| NCT00726986 | Terminated | Phase 2 | Sorafenib, Cisplatin, and Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer | July 2008 | July 2012 |
| NCT00660036 | Terminated | Phase 1 | Phase I/II Study of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin for Acute Myeloid Leukemia | September 2008 | April 2011 |
| NCT00632827 | Terminated | Phase 2 | Treatment of PTCL With Aggressive Induction Therapy Followed by Autologous SCT Using Denileukin Diftitox (Ontak) | July 1, 2008 | June 23, 2016 |
| NCT00630565 | Terminated | Phase 2/Phase 3 | Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia | July 26, 2006 | July 28, 2022 |
| NCT00623077 | Terminated | Phase 1 | MT2004-30: Tomotherapy for Solid Tumors | August 2005 | October 2016 |
| NCT02349178 | Terminated | Phase 2 | Bridging Study to Eliminate Presence of MRD for Acute Leukemia Before HCT | December 8, 2014 | March 16, 2017 |
| NCT02359162 | Terminated | Phase 3 | Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early Stage | May 2015 | June 2017 |
| NCT02366663 | Terminated | Phase 3 | BEAM vs. 90-Yttrium Ibritumomab Tiuxetan (Zevalin®)/BEAM With ASCT for Relapsed DLBCL | January 2015 | October 2016 |
| NCT00540995 | Terminated | Phase 1/Phase 2 | Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer | June 11, 2007 | August 9, 2011 |
| NCT00539500 | Terminated | Phase 2/Phase 3 | Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma | October 2007 | September 5, 2012 |
| NCT00537511 | Terminated | Phase 1/Phase 2 | A Phase I/II Study to Determine the Maximum Tolerated Dose (MTD) and Safety of CC-4047 (Pomalidomide) Administered in Conjunction With Cisplatin and Etoposide | February 1, 2008 | December 1, 2010 |
| NCT00529503 | Terminated | Phase 2 | A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL | September 2007 | May 2011 |
| NCT00505921 | Terminated | Phase 2 | Autologous and Allogenic Transplantation With Campath-1H for T-Cell Lymphoma | March 2003 | November 2009 |
| NCT00500890 | Terminated | Phase 3 | Treatment of Tumors of the Choroid Plexus Epithelium | September 2, 2005 | December 14, 2017 |
| NCT00482053 | Terminated | Phase 2 | Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT | October 2006 | May 2010 |
| NCT02483000 | Terminated | Phase 1 | Anti-CD20 Radioimmunotherapy Before Chemotherapy and Stem Cell Transplant in Treating Patients With High-Risk B-Cell Malignancies | February 1, 2017 | September 2, 2020 |
| NCT00481832 | Terminated | Phase 2 | Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma | January 2007 | March 30, 2017 |
| NCT00417248 | Terminated | Phase 1/Phase 2 | Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer | June 2007 | April 2008 |
| NCT02518750 | Terminated | Phase 2 | Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma | November 23, 2016 | March 11, 2018 |
| NCT00354107 | Terminated | Phase 1/Phase 2 | Ifosfamide, Carboplatin, Etoposide, and SGN-30 in Treating Young Patients With Recurrent Anaplastic Large Cell Lymphoma | January 2007 | January 2010 |
| NCT00351195 | Terminated | Phase 2 | Etoposide, Oxaliplatin and Capecitabine in Advanced Hepatocellular Carcinoma (HCC) | February 2006 | April 2007 |
| NCT02592876 | Terminated | Phase 2 | Treatment Study of Denintuzumab Mafodotin (SGN-CD19A) Plus RICE Versus RICE Alone for Diffuse Large B-Cell Lymphoma | October 2015 | April 20, 2018 |
| NCT02631252 | Terminated | Phase 1 | Phase I Study of Mitoxantrone and Etoposide Combined With Hydroxychloroquine, for Relapsed Acute Myelogenous Leukemia | August 18, 2016 | October 2, 2017 |
| NCT00281879 | Terminated | Phase 2 | Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer | February 2006 | March 2008 |
| NCT02653196 | Terminated | Early Phase 1 | A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors | September 2015 | August 2017 |
| NCT02703272 | Terminated | Phase 3 | A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma | July 1, 2016 | June 11, 2021 |
| NCT02722369 | Terminated | Phase 2 | STUDY 15 - Comparing Gemcitabine/Carboplatin and Hydroxychloroquine Versus Carboplatin/Etoposide Therapy Alone in Small Cell Lung Cancer (SCLC) | March 14, 2017 | March 12, 2021 |
| NCT02748889 | Terminated | Phase 1/Phase 2 | Carboplatin Plus Etoposide With or Without MPDL3280A in Untreated Extensive Stage Small Cell Lung Cancer | March 2016 | May 9, 2017 |
| NCT02768558 | Terminated | Phase 3 | Cisplatin and Etoposide Plus Radiation Followed By Nivolumab/Placebo For Locally Advanced NSCLC | October 17, 2016 | January 23, 2019 |
| NCT02773732 | Terminated | Phase 1/Phase 2 | Clinical Trial of Oral Ciprofloxacin and Etoposide in Subjects With Resistant Acute Myeloid Leukemia (AML)(UF-AML-CE-101) | December 16, 2016 | November 15, 2021 |
| NCT00253552 | Terminated | N/A | G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders | May 2004 | May 2006 |
| NCT00225173 | Terminated | Phase 2 | Combination Chemotherapy +/- Radiation in High Risk Hodgkin's Disease | October 2001 | September 2006 |
| NCT02819999 | Terminated | Phase 1 | A Study of Rovalpituzumab Tesirine (SC16LD6.5) in the Frontline Treatment of Patients With Extensive Stage Small Cell Lung Cancer | October 2016 | May 31, 2019 |
| NCT00126191 | Terminated | Phase 2 | Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma | July 2005 | June 2011 |
| NCT02899728 | Terminated | Phase 2 | Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer | March 30, 2018 | March 17, 2020 |
| NCT02934503 | Terminated | Phase 2 | Study of Pembrolizumab and Chemotherapy With or Without Radiation in Small Cell Lung Cancer (SCLC) | January 23, 2017 | October 1, 2019 |
| NCT00124644 | Terminated | Phase 1 | Combination Chemotherapy and Tipifarnib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia | March 2006 | January 2008 |
| NCT00101205 | Terminated | Phase 1 | Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma | November 2004 | |
| NCT02987998 | Terminated | Phase 1 | Neoadjuvant Chemoradiation Plus Pembrolizumab Followed By Consolidation Pembrolizumab in NSCLC | May 19, 2017 | November 28, 2022 |
| NCT00074490 | Terminated | Phase 2 | Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers | January 1, 2004 | August 16, 2017 |
| NCT00074165 | Terminated | Phase 2 | Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen | January 2003 | December 2010 |
| NCT00060385 | Terminated | Phase 2/Phase 3 | Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma | March 2003 | |
| NCT00058461 | Terminated | Phase 2 | Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia | November 2003 | |
| NCT03041311 | Terminated | Phase 2 | Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC | June 29, 2017 | October 29, 2020 |
| NCT00045617 | Terminated | Phase 2 | S0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung Cancer | January 2003 | May 2003 |
| NCT00042835 | Terminated | Phase 1 | Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer | May 2002 | |
| NCT00031590 | Terminated | Phase 2 | Low-Dose Radiation and Combination Chemotherapy Following Surgery in Children With Newly Diagnosed Medulloblastoma | April 2001 | May 2011 |
| NCT03116971 | Terminated | Phase 1 | Phase Ib/II Study of M3814 With Etoposide and Cisplatin in Small Cell Lung Cancer (SCLC) Extensive Disease (ED) | May 25, 2017 | March 1, 2018 |
| NCT00021112 | Terminated | Phase 2 | Combination Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer | April 2001 | |
| NCT00014313 | Terminated | Phase 2 | Chemotherapy in Treating Patients With Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor | January 2001 | |
| NCT00006708 | Terminated | Phase 3 | S0019 Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | October 2000 | November 2006 |
| NCT00006054 | Terminated | N/A | Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies | March 2000 | December 2002 |
| NCT03735446 | Terminated | Phase 1 | Prexasertib in Combination With MEC in Relapsed/Refractory AML and High Risk MDS - a Phase I Trial | January 18, 2019 | March 29, 2019 |
| NCT00006032 | Terminated | Phase 2 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer | March 2000 | April 2001 |
| NCT00005987 | Terminated | Phase 2 | Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma | August 2000 | July 2003 |
| NCT00005834 | Terminated | Phase 3 | S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple Myeloma | April 2000 | November 2007 |
| NCT03840902 | Terminated | Phase 2 | M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) | April 16, 2019 | February 17, 2023 |
| NCT00005612 | Terminated | Phase 1/Phase 2 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer | August 1999 | February 2004 |
| NCT03860844 | Terminated | Phase 2 | Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia | August 6, 2019 | May 26, 2023 |
| NCT03864419 | Terminated | Phase 1 | Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda | October 24, 2019 | July 26, 2023 |
| NCT00005090 | Terminated | Phase 3 | S9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's Disease | April 2000 | May 2005 |
| NCT00003852 | Terminated | Phase 2 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors | March 1998 | March 2000 |
| NCT04189952 | Terminated | Phase 2 | Acalabrutinib in Combination With R-ICE For Relapsed or Refractory Lymphoma | September 22, 2020 | March 1, 2022 |
| NCT04326439 | Terminated | Phase 2 | AflacLL1901 (CHOA-AML) | January 24, 2020 | March 15, 2022 |
| NCT04356690 | Terminated | Phase 2 | Etoposide in Patients With COVID-19 Infection | May 8, 2020 | July 1, 2022 |
| NCT04372927 | Terminated | Phase 2 | ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapy | December 10, 2021 | April 23, 2022 |
| NCT04422210 | Terminated | Phase 1 | A Study Evaluating The Safety, Tolerability, Pharmacokinetics, And Efficacy Of Venetoclax In Combination With Atezolizumab, Carboplatin, And Etoposide In Participants With Untreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC). | September 22, 2020 | November 6, 2020 |
| NCT00003380 | Terminated | Phase 1 | Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer | May 1998 | |
| NCT04610684 | Terminated | Phase 2 | Chemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Asymptomatic Brain Metastases | January 5, 2021 | September 20, 2022 |
| NCT00003194 | Terminated | Phase 1 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors | July 1997 | December 19, 2002 |
| NCT00003113 | Terminated | Phase 2 | Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas | July 1997 | December 2002 |
| NCT00002961 | Terminated | Phase 3 | Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia | October 1995 | February 2001 |
| NCT04870112 | Terminated | Phase 1 | A Study to Evaluate Subcutaneous Durvalumab in Patients With Non-Small Cell Lung Cancer and Small Cell Lung Cancer | June 28, 2021 | August 30, 2023 |
| NCT00002478 | Terminated | Phase 2 | Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer | June 1993 | |
| NCT01722292 | Terminated | Phase 1/Phase 2 | A Study of LY2940680 in Small Cell Lung Cancer | January 2013 | February 2015 |
| NCT01746173 | Terminated | Phase 2 | CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma | July 2013 | October 2014 |
| NCT01653418 | Terminated | Phase 2 | Phase II Study of V-BEAM Conditioning Regimen Prior to Second Autologous Stem Cell Transplantation | September 2012 | December 2013 |
| NCT01573338 | Terminated | Phase 1/Phase 2 | Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 When Given Together With Chemotherapy and the Effectiveness of This Combination Treatment in Shrinking a Specific Type of Lung Tumors (Small Cell Lung Cancer) | February 25, 2013 | June 23, 2016 |
| NCT01822496 | Terminated | Phase 2 | Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | November 4, 2013 | June 4, 2018 |
| NCT01565772 | Terminated | Phase 1 | Proton Radiation Therapy With Cisplatin and Etoposide Followed by Surgery in Stage III Non-Small Cell Lung Cancer | March 2012 | June 2015 |
| NCT01548573 | Terminated | Phase 2 | Tandem Auto Transplantation in Myeloma Patients With <12 Months of Prior Treatment | May 2012 | August 2014 |
| NCT01500161 | Terminated | Phase 2 | Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match | November 2011 | November 2013 |
| NCT01859741 | Terminated | Phase 1/Phase 2 | A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Etoposide and Platinum Therapy | January 7, 2012 | May 8, 2017 |
| NCT03553238 | Unknown status | Phase 2/Phase 3 | Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL | February 14, 2016 | August 30, 2020 |
| NCT04061772 | Unknown status | Phase 2 | A Study of Bortezomib Combined With CHEP in Peripheral T Cell Lymphoma | August 12, 2019 | December 5, 2021 |
| NCT04077905 | Unknown status | Phase 3 | Pegylated Liposomal Doxorubicin as a Induction Therapy for Lymphoma Induced Hemophagocytic Lymphohistiocytosis. | August 31, 2019 | July 31, 2021 |
| NCT00003643 | Unknown status | Phase 2/Phase 3 | Combination Chemotherapy in Treating Men With Germ Cell Cancer | October 1998 | |
| NCT00003602 | Unknown status | Phase 3 | Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia | March 1998 | |
| NCT00360750 | Unknown status | N/A | Chemotherapy With or Without Radiation Therapy or Observation in Treating Young Patients With Advanced Retinoblastoma Who Have Undergone Surgery to Remove the Eye | September 2005 | |
| NCT00379457 | Unknown status | Phase 3 | Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma | June 2006 | |
| NCT00392886 | Unknown status | Phase 3 | Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors | March 2004 | |
| NCT00416676 | Unknown status | Phase 3 | Combination Chemotherapy and Surgery With or Without Radiation Therapy in Treating Patients With Stage 2 or Stage 3 Neuroblastoma | ||
| NCT01468740 | Unknown status | Phase 2 | Prospective Study on HIV-related Hodgkin Lymphoma | March 2004 | July 2012 |
| NCT02348450 | Unknown status | Phase 4 | Irinotecan Plus Cisplatin Compared With Etoposide Plus Cisplatin for Extensive Stage Small-cell Lung Cancer | February 2015 | December 2018 |
| NCT00550992 | Unknown status | N/A | Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia | January 2006 | |
| NCT00616785 | Unknown status | Phase 2 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery | June 2007 | |
| NCT00669812 | Unknown status | Phase 2 | High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma | February 2008 | |
| NCT00720447 | Unknown status | Phase 2 | Donor Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma | November 2008 | |
| NCT03700359 | Unknown status | Phase 2 | A Study of Lobaplatin/Etoposide With or Without Anlotinib Maintenance Therapy in Patients With ES-SCLC | March 1, 2019 | November 29, 2021 |
| NCT03711305 | Unknown status | Phase 3 | Study of Carboplatin Plus Etoposide With or Without SHR-1316 in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC) | December 30, 2018 | December 2023 |
| NCT03617432 | Unknown status | Phase 2 | Chidamide Combined With CHOPE Regimen for Peripheral T-cell Lymphoma Patients | August 28, 2018 | September 30, 2022 |
| NCT00764907 | Unknown status | Phase 3 | Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia | November 2002 | |
| NCT03583424 | Unknown status | Phase 1/Phase 2 | Venetoclax, Carmustine, Etoposide, Cytarabine, and Melphalan Before Stem Cell Transplant in Treating Participants With Relapsed or Refractory Non-Hodgkin Lymphoma | September 10, 2018 | December 31, 2022 |
| NCT03742115 | Unknown status | Phase 3 | Etoposide in the First-line Treatment of Adult EBV-HLH | December 1, 2018 | December 1, 2020 |
| NCT00006045 | Unknown status | Phase 3 | Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia | March 2000 | |
| NCT00006056 | Unknown status | N/A | Pilot Study of Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Life Threatening Hemophagocytic Disorders | March 2000 | |
| NCT02179528 | Unknown status | Phase 2 | Study of Small Doses of Etoposide as Maintenance Treatment in Small Cell Lung Cancer(SCLC) | September 2014 | September 2017 |
| NCT00002481 | Unknown status | Phase 2 | Combination Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | March 1990 | |
| NCT00908180 | Unknown status | Phase 2 | Carmustine, Etoposide, Cytarabine, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma | July 2009 | |
| NCT00002488 | Unknown status | Phase 2 | Combination Chemotherapy in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma Who Have Not Responded to Anthracycline-Containing Combination Chemotherapy | December 1991 | |
| NCT03923179 | Unknown status | Phase 2 | Phase II Clinical Study of Pyrotinib Combined With Etoposide to Treat HER2-positive Advanced Breast Cancer | April 19, 2019 | December 31, 2021 |
| NCT00004903 | Unknown status | Phase 2 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma | October 1999 | |
| NCT00004128 | Unknown status | Phase 3 | Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia | September 1999 | |
| NCT03963193 | Unknown status | Phase 2 | Etoposide/Cisplatin Compared With Irinotecan/Cisplatin for Advanced Gastrointestinal Neuroendocrine Tumor G3 Type | June 1, 2019 | June 1, 2021 |
| NCT00004086 | Unknown status | Phase 1 | Radiolabeled Monoclonal Antibody, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory B-Cell Cancer | June 1997 | |
| NCT02099188 | Unknown status | Phase 2 | Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable Patients | November 2013 | January 2024 |
| NCT00003815 | Unknown status | Phase 3 | Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma | June 1994 | |
| NCT04000295 | Unknown status | Phase 3 | Apatinib and Etoposide Capsule Versus Weekly Paclitaxel in Patients With Platinum Resistant Ovarian Cancer | August 16, 2019 | July 2022 |
| NCT00003728 | Unknown status | Phase 3 | Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma | December 1998 | |
| NCT03564704 | Unknown status | Phase 2/Phase 3 | Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL | February 14, 2016 | May 30, 2021 |
| NCT00003696 | Unknown status | Phase 3 | Combination Chemotherapy in Treating Patients Who Have Extensive-Stage Small Cell Lung Cancer | October 1998 | |
| NCT00003583 | Unknown status | Phase 2 | Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer | June 1997 | |
| NCT04189094 | Unknown status | Phase 2 | Chemoradiotherapy With or Without Sintilimab in Limited-stage SCLC | January 1, 2020 | July 1, 2023 |
| NCT02099175 | Unknown status | Phase 2 | Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients | November 2013 | January 2024 |
| NCT00011921 | Unknown status | Phase 3 | Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplant Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung Cancer | September 1997 | |
| NCT04234607 | Unknown status | Phase 3 | A Study of TQB2450 or Placebo Combined With Anlotinib, Etoposide and Carboplatin Versus Etoposide and Carboplatin in Subjects With Extensive Small Cell Lung Cancer (ETER701) | January 2020 | December 2022 |
| NCT00003578 | Unknown status | Phase 3 | High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma | January 1993 | |
| NCT00003558 | Unknown status | Phase 3 | Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin | August 1998 | |
| NCT00012311 | Unknown status | Phase 2 | Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer | January 2000 | |
| NCT00016887 | Unknown status | Phase 3 | Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplant Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma | December 2000 | |
| NCT02015728 | Unknown status | N/A | Selecting Patient-Specific Biologically Targeted Therapy for Pediatric Patients With Refractory Or Recurrent Brain Tumors | December 2013 | December 2017 |
| NCT00003423 | Unknown status | Phase 3 | Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma | May 1995 | |
| NCT04405375 | Unknown status | Phase 2 | GPED Regimen for Relapsed/Refractory or Advanced ENKTCL | March 21, 2020 | April 30, 2023 |
| NCT01857453 | Unknown status | Phase 2 | Interest of a Dose Decrease for Radiotherapy Associated With Chemotherapy for Treatment of Standard Risk Adult Medulloblastomas | April 10, 2013 | December 2021 |
| NCT03367143 | Unknown status | Phase 2 | Lenalidomide Plus ICE in the Treatment of Refractory and Relapsed DLBCL | December 2016 | December 2020 |
| NCT01492556 | Unknown status | Phase 2 | Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast Cancer | December 2011 | June 2015 |
| NCT00020566 | Unknown status | Phase 3 | Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma | February 2001 | |
| NCT03321890 | Unknown status | Phase 2 | Chidamide Combined With PECM in Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) | March 7, 2017 | December 31, 2020 |
| NCT03298074 | Unknown status | Phase 2 | Apatinib Plus Etoposide Versus Etoposide Alone for Platinum-resistant Recurrent Ovarian Cancer | October 2017 | April 2019 |
| NCT00024193 | Unknown status | Phase 2 | Chemotherapy and Surgery Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Neuroblastoma | April 1999 | |
| NCT00025064 | Unknown status | Phase 2 | Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplant in Treating Children With Hodgkin's Lymphoma | January 2000 | |
| NCT00025103 | Unknown status | Phase 2 | Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney | May 2001 | |
| NCT01172912 | Unknown status | Phase 2 | High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy | October 2010 | |
| NCT00003284 | Unknown status | Phase 2 | High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung Cancer | January 1998 | |
| NCT00025324 | Unknown status | Phase 2 | Chemotherapy, Surgery, Radiation Therapy and Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Primary CNS Germ Cell Tumors | December 2000 | |
| NCT00003262 | Unknown status | Phase 2 | Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection | May 1997 | |
| NCT00025402 | Unknown status | Phase 3 | Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia | July 1997 | |
| NCT00025636 | Unknown status | Phase 3 | Combination Chemotherapy and Peripheral Stem Cell Transplant in Treating Patients With Relapsed Hodgkin's Lymphoma | July 2001 | |
| NCT04684017 | Unknown status | Phase 2 | Anlotinib Plus Etoposide and Carboplatin as First-line Treatment for Extensive-stage Small Cell Lung Cancer | May 1, 2019 | January 1, 2022 |
| NCT00030719 | Unknown status | Phase 3 | Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma | December 2001 | |
| NCT03071822 | Unknown status | Phase 4 | Combination Chemotherapy Including Cisplatin, Ifosfamide, Gemcitabine, L-asparaginase, Etoposide and Dexamethasone as Treatment of Newly Diagnosed and Relapsed/Refractory Peripheral T Cell Lymphomas | February 24, 2017 | February 28, 2022 |
| NCT04696939 | Unknown status | Phase 2 | Combined Atezolizumab and Chemotherapy (Carboplatin Plus Etoposide) in Neoadjuvant Treating Limited-Stage Small Cell Lung Cancer Patients | January 2021 | October 2023 |
| NCT00032149 | Unknown status | Phase 1/Phase 2 | Combination Chemotherapy Plus Filgrastim in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma | October 2001 | |
| NCT00041210 | Unknown status | Phase 3 | Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma | October 2001 | |
| NCT03061656 | Unknown status | Phase 2 | Tandem High Dose Chemotherapy With 131I-MIBG Treatment in High Risk Neuroblastoma | January 1, 2009 | December 31, 2018 |
| NCT00003053 | Unknown status | Phase 3 | Combination Chemotherapy in Treating Patients With Stage I, II, or IIIA Non-small Cell Lung Cancer That Has Been Surgically Removed | January 1994 | |
| NCT04740021 | Unknown status | Phase 2 | Study of LP002 in Combination With Chemotherapy for Patients With Extensive Stage Small Cell Lung Cancer | December 2, 2020 | August 1, 2022 |
| NCT00002987 | Unknown status | Phase 3 | Combination Chemotherapy Given With Radiation Therapy or Radiation Therapy Alone in Treating Patients With Early-Stage Hodgkin's Disease | January 1997 | |
| NCT00047138 | Unknown status | Phase 3 | Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor | January 2001 | |
| NCT01555710 | Unknown status | Phase 3 | Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study) | May 2012 | June 2015 |
| NCT00002926 | Unknown status | Phase 3 | Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia | December 1996 | |
| NCT03018626 | Unknown status | Phase 3 | R-ACVBP and DA-EPOCH-R in Patients With Non-GCB DLBCL | July 27, 2017 | January 2021 |
| NCT00083083 | Unknown status | Phase 2 | Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer | March 2005 | |
| NCT02987244 | Unknown status | Phase 1/Phase 2 | Chidamide Plus CHOEP Combined With Upfront ASCT in Untreated Peripheral T-cell Lymphoma | March 2016 | March 2023 |
| NCT00002905 | Unknown status | Phase 2 | Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma | June 1995 | |
| NCT04917250 | Unknown status | Phase 2 | GPED for Patients With Relapsed/Refractory or Advanced NK/T-cell Lymphoma | March 20, 2020 | August 31, 2021 |
| NCT02949258 | Unknown status | Phase 2 | Neoadjuvant Chemotherapy With SEEOX Regimen for Borrmann Type 4 Gastric Cancer | January 2017 | January 2021 |
| NCT00002887 | Unknown status | Phase 1 | Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer | July 1995 | |
| NCT00002858 | Unknown status | Phase 3 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer | March 1993 | |
| NCT00002701 | Unknown status | Phase 3 | Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia | October 1995 | |
| NCT02912702 | Unknown status | Phase 3 | L-DEP as an Initial Treatment for EBV-HLH | September 2016 | September 2019 |
| NCT00131027 | Unknown status | Phase 3 | High-Dose Methotrexate (MTX) for Adult Acute Lymphoblastic Leukemia (ALL) | September 2002 | September 2011 |
| NCT00002688 | Unknown status | Phase 2 | Cyclosporine and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | February 1995 | |
| NCT00199147 | Unknown status | Phase 4 | Efficacy of G-CSF-Priming in Elderly AML Patients | January 2000 | |
| NCT00002658 | Unknown status | Phase 3 | Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia | January 1994 | |
| NCT05049473 | Unknown status | Phase 2 | Treatment of Mature B-ALL and Burkitt Lymphoma (BL) in Adult Patients. BURKIMAB-14. | January 2014 | January 2024 |
| NCT02858804 | Unknown status | Phase 4 | EDOCH Alternating With DHAP for New Diagnosed Younger MCL | January 2016 | June 2020 |
| NCT02848183 | Unknown status | Phase 2 | Optimal Treatment Strategy Based on for Pediatric AML | January 2016 | |
| NCT00002557 | Unknown status | Phase 2 | Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides | June 1993 | |
| NCT02836639 | Unknown status | Phase 2 | BEB Conditioning Regimen for Autologous Stem-cell Transplantation(ASCT) in Non-Hodgkin's Lymphoma | February 2016 | |
| NCT00002549 | Unknown status | Phase 3 | Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia | November 1993 | |
| NCT00209222 | Unknown status | Phase 3 | Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL | July 2004 | December 2014 |
| NCT00209833 | Unknown status | Phase 2/Phase 3 | Treatment of Adults Aged Up to 60 Years With De Novo Acute Myeloblastic Leukaemia,Secondary AML, or RAEB-T | January 1999 | September 2005 |
| NCT00002532 | Unknown status | Phase 2 | Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia | January 1993 | |
| NCT00274950 | Unknown status | Phase 3 | Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors | May 2005 | |
| NCT00002531 | Unknown status | Phase 2 | Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia | January 1993 | |
| NCT02784054 | Unknown status | Phase 2 | Reduced Dose Radiotherapy Following High Dose Chemotherapy in Intracranial Non-germinomatous Germ Cell Tumor | April 2014 | March 2023 |
| NCT02784015 | Unknown status | Phase 2 | Response Based Treatment for Children With Unresectable Localized Soft Tissue Sarcoma | May 2016 | May 2023 |
| NCT02782754 | Unknown status | Phase 2 | Chemotherapy Plus Reduced Radiotherapy in Intracranial Germinoma | January 2013 | |
| NCT00002516 | Unknown status | Phase 3 | Combination Chemotherapy Plus Surgery and Radiation Therapy in Treating Patients With Ewing's Sarcoma | July 1992 | |
| NCT02771743 | Unknown status | Phase 2 | Response-based Treatment of High-risk Neuroblastoma | April 2015 | March 2023 |
| NCT00276718 | Unknown status | N/A | Etoposide, Carboplatin, and Bleomycin in Treating Young Patients Undergoing Surgery For Malignant Germ Cell Tumors | April 1989 | |
| NCT02738346 | Unknown status | Phase 3 | SCLC on the 2nd Line With Relapsed After Response to Chemotherapy GFPC 01-2013 | July 2013 | July 2017 |
| NCT02733107 | Unknown status | Phase 2 | The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer | March 2016 | December 2020 |
| NCT00276731 | Unknown status | Phase 3 | Combination Chemotherapy Followed By Surgery With or Without Radiation Therapy in Treating Young Patients With Stage II or Stage III Neuroblastoma | March 1995 | |
| NCT00278252 | Unknown status | Phase 2 | Etoposide in Treating Young Patients With Relapsed Ependymoma | July 2001 | |
| NCT02660762 | Unknown status | Phase 2 | Modified MRCUKALLⅫ/ECOGE2993 Regimen for ALL | January 2016 | January 2019 |
| NCT02638428 | Unknown status | Phase 2 | Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy | December 2015 | December 2023 |
| NCT00278278 | Unknown status | Phase 3 | Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed Gliomas | September 2003 | |
| NCT02631239 | Unknown status | Phase 3 | MESA Versus ESA in the Treatment of Early Stage NK/T-cell Lymphoma | March 16, 2016 | July 17, 2022 |
| NCT02631109 | Unknown status | Phase 3 | L-DEP Regimen as a Salvage Therapy for Refractory Epstein Barr Virus-induced Hemophagocytic Lymphohistiocytosis | December 2015 | November 2019 |
| NCT00287950 | Unknown status | N/A | Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Infants With Neuroblastoma | September 1992 | |
| NCT00324467 | Unknown status | Phase 2 | Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment | August 2006 | December 2021 |
| NCT00334672 | Unknown status | Phase 3 | Combination Chemotherapy Followed By Donor Stem Cell Transplant in Treating Patients With Hemophagocytic Lymphohistiocytosis | March 2006 | |
| NCT02582697 | Unknown status | Phase 3 | Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours | February 2014 | July 2023 |
| NCT02549261 | Unknown status | N/A | Nimotuzumab in Combination With Radiochemotherapy for Patients With Stage IIIA/IIIB Non-small Cell Lung Cancer | March 2011 | December 2015 |
| NCT02544425 | Unknown status | Phase 2 | VP-16, Ifosfamide, Dexamethasone, L-asparaginase Chemotherapy in Patients With Extranodal Natural Killer T Cell Lymphoma (VIDL+ASCT) | February 21, 2016 | November 30, 2021 |
| NCT04116359 | Withdrawn | Phase 1/Phase 2 | Testing of the Addition of a New Anti-cancer Drug, Molibresib, to Chemotherapy Treatment (Etoposide and Cisplatin) for Patients With NUT Carcinoma | September 18, 2020 | September 18, 2020 |
| NCT00006669 | Withdrawn | Phase 2 | Rituximab Followed by Combination Chemotherapy in Treating Patients With Refractory or Recurrent Non-Hodgkin's Lymphoma | September 1999 | January 2000 |
| NCT03531281 | Withdrawn | Phase 1 | Human Lysozyme Goat Milk in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant | December 30, 2018 | December 30, 2022 |
| NCT00003273 | Withdrawn | Phase 2 | Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor | November 1997 | |
| NCT03515707 | Withdrawn | Phase 2 | Stem Cell Transplant to Treat Patients With Favorable or Intermediate Risk Minimal Residual Disease Negative Acute Myeloid Leukemia | July 10, 2018 | July 30, 2022 |
| NCT01795430 | Withdrawn | N/A | Whole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue in Treating Patients With Poor-Risk Ewing Sarcoma | July 2013 | |
| NCT00006126 | Withdrawn | Phase 1 | Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery | September 1999 | April 2001 |
| NCT04203511 | Withdrawn | Phase 3 | INCMGA00012 in Combination With Chemoradiation in Participants With Stage III Non-Small Cell Lung Cancer (POD1UM-301) | July 31, 2020 | January 31, 2025 |
| NCT00009815 | Withdrawn | Phase 1 | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | December 1999 | |
| NCT01769911 | Withdrawn | N/A | Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma | February 2015 | |
| NCT00006374 | Withdrawn | Phase 2 | Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer | October 1999 | June 2001 |
| NCT02538926 | Withdrawn | Phase 2 | Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma | July 1, 2018 | July 30, 2021 |
| NCT00972101 | Withdrawn | Phase 1 | Infusion of Expanded Cord Blood T Cells | September 2009 | September 2011 |
| NCT05161533 | Withdrawn | Phase 2 | Hypofractionated Radiation Therapy After Durvalumab and Chemotherapy for the Treatment of Stage IV Extensive Stage Small Cell Lung Cancer, CASPIAN-RT Trial | October 19, 2023 | December 31, 2024 |
| NCT00723658 | Withdrawn | Phase 2 | S0629, Observation or Combination Chemotherapy, Bortezomib, Thalidomide, and Rituximab Followed By Two Autologous Peripheral Blood Stem Cell Transplants in Treating Patients With Waldenstrom Macroglobulinemia | September 2008 | |
| NCT00983944 | Withdrawn | Phase 2 | Rituximab and Combination Chemotherapy With or Without Bleomycin Sulfate in Treating Patients With Primary Mediastinal Large B-Cell Lymphoma | September 2009 | April 25, 2011 |
| NCT02947113 | Withdrawn | Phase 2 | Combination of Platinum Doublets and Hypofractionated Radiotherapy in NSCLC | November 2017 | November 2017 |
| NCT01055301 | Withdrawn | Phase 2 | S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma | July 2011 | July 2011 |
| NCT02228512 | Withdrawn | Phase 1/Phase 2 | Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas | August 15, 2014 | May 5, 2015 |
| NCT00005998 | Withdrawn | Phase 2 | Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease | January 2000 | March 2003 |
| NCT01677949 | Withdrawn | Phase 2 | Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia | December 2013 | January 2016 |
| NCT04989283 | Withdrawn | Phase 2 | Testing the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy Treatment During Radiation Therapy for Superior Sulcus Non-small Cell Lung Cancer | September 9, 2021 | May 10, 2031 |
| NCT03349346 | Withdrawn | Phase 1 | Idelalisib With Rituximab, Ifosfamide, Carboplatin, Etoposide (RICE) in Children and Adolescents | June 2019 | February 2026 |
| NCT05228249 | Withdrawn | Phase 1 | Loncastuximab Tesirine in Combination With Chemotherapy Prior to Stem Cell Transplant for the Treatment of Recurrent or Refractory Diffuse Large B-Cell Lymphoma | April 2023 | October 1, 2027 |
| NCT04521946 | Withdrawn | Phase 1 | Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer | January 14, 2021 | December 20, 2022 |
| NCT05711628 | Withdrawn | Phase 3 | A Trial Comparing Chemotherapy Versus Novel Immune Checkpoint Inhibitor (Pembrolizumab) Plus Chemotherapy in Treating Relapsed/Refractory Classical Hodgkin Lymphoma | August 10, 2023 | June 30, 2028 |
| NCT02408042 | Withdrawn | Phase 1/Phase 2 | Study of Pembrolizumab With Chemotherapy in Patients With Advanced Lymphoma (PembroHeme) | April 2015 | November 2015 |
| NCT00310128 | Withdrawn | Phase 2 | Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma | February 2006 | |
| NCT03579927 | Withdrawn | Phase 1/Phase 2 | CAR.CD19-CD28-zeta-2A-iCasp9-IL15-Transduced Cord Blood NK Cells, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Participants With B-cell Lymphoma | October 3, 2019 | October 3, 2019 |
| NCT00829205 | Withdrawn | Phase 1/Phase 2 | Se-Methyl-Seleno-L-Cysteine, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment | January 2009 | |
| NCT01415765 | Withdrawn | Phase 1/Phase 2 | MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell Lymphoma | July 15, 2011 | January 7, 2014 |
| NCT00916669 | Withdrawn | Phase 2 | A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC) | July 2008 | |
| NCT00334867 | Withdrawn | Phase 3 | Combination Chemotherapy With or Without Topotecan in Treating Patients With Newly Diagnosed Localized Ewing's Sarcoma | December 2005 |